Detection and Analysis of Molecular Interactions with Backscattering Interferometry by Haddad-Weiser, Gabrielle Lee
Lehigh University
Lehigh Preserve
Theses and Dissertations
2016
Detection and Analysis of Molecular Interactions
with Backscattering Interferometry
Gabrielle Lee Haddad-Weiser
Lehigh University
Follow this and additional works at: http://preserve.lehigh.edu/etd
Part of the Chemistry Commons
This Dissertation is brought to you for free and open access by Lehigh Preserve. It has been accepted for inclusion in Theses and Dissertations by an
authorized administrator of Lehigh Preserve. For more information, please contact preserve@lehigh.edu.
Recommended Citation
Haddad-Weiser, Gabrielle Lee, "Detection and Analysis of Molecular Interactions with Backscattering Interferometry" (2016). Theses
and Dissertations. 2623.
http://preserve.lehigh.edu/etd/2623
  
Detection and Analysis of Molecular Interactions with Backscattering Interferometry 
 
 
 
by 
 
 
Gabrielle Lee Haddad-Weiser 
 
 
 
 
 
 
A Dissertation 
 
Presented to the Graduate and Research Committee 
 
of Lehigh University 
 
in Candidacy for the Degree of 
 
Doctor of Philosophy 
 
 
 
 
 
 
 
in 
 
Chemistry 
 
 
 
 
Lehigh University 
 
August 2, 2016 
 
 
 
 ii 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
© 2016 Copyright 
Gabrielle Lee Haddad-Weiser 
 
  
 iii 
 
 Approved and recommended for acceptance as a dissertation in partial fulfillment 
of the requirements for the degree of Doctor of Philosophy 
 
Gabrielle Lee Haddad-Weiser 
Detection and Analysis of Molecular Interactions with Backscattering Interferometry 
 
 
 
August 2, 2016 
                                                 
Defense Date 
 
                                                                     
        Dissertation Director 
        Dr. Robert A. Flowers II 
                                                                                                 
Approved Date    
                                                                  
     
                                                                     
 
        Committee Members: 
 
 
                                                                      
        Dr. K. Jebrell Glover 
 
 
                                                                      
        Dr. Damien Thevenin 
 
 
                                                                      
        Dr. Bryan Berger 
 
 
         
 
                (Name of Committee Member) 
 
      
 
 
 iv 
Acknowledgements 
 
The completion of this dissertation would not have been possible without the 
assistance and support of many wonderful people.  First, thank you to my adviser, Dr. 
Flowers, for all your guidance, patience, and mentoring.  Thank you to my 
committee, Dr. Glover, Dr. Thevenin, and Dr. Berger, for taking the time to assist me 
in this degree and offering helpful suggestions and comments.  Thank you to my 
awesome group members, both former and present, for proofreading papers and 
chapters, helpful suggestions, support, and insightful discussions about the latest 
Disney movie.  An especially huge shout-out to Dr. Esther Pesciotta, who started the 
BSI project here at Lehigh, and taught me everything she knew about the instrument, 
helped get me started in BSI research, and continued to offer help and answer 
questions even years after completing her degree. 
I would also like to thank our collaborators at Vanderbilt University, Dr. 
Bornhop and Dr. Amanda Kussrow, for answering many questions over the years, 
helping me learn the intricate details of instrument alignment, providing new versions 
of LabView when our computer crashed, and allowing me time to work with the 
Vanderbilt instruments, and to Michael Kammerer for help with structure calculations 
and FreeSRF details.  Thank you to Bill Anderson for help with computed structures, 
as well.  I would also like to thank all of the Lehigh and Moravian chemistry 
professors I’ve worked with and learned from over the years. 
Many thanks as well to my dissertation writing buddies, Dr. Natalie Hernandez 
and Dr. Vincent Zoutenbier, for the camaraderie and to Jenny’s Kuali for supplying 
 v 
extra fortune cookies during those late night writing sessions.  And finally, thank you 
to my amazing and ever-supportive family and especially to my awesomely 
wonderful husband, Philip Weiser.  Your constant support especially means the world 
to me, and I would not have been able to complete this dissertation without you by 
my side.  Now it’s your turn to write yours!  Thank you for always being my rock, 
offering support, listening to me vent, and sneaking candy into my purse. 
  
 vi 
TABLE OF CONTENTS 
 
 
 
 
List of Figures          viii 
 
List of Tables          xi 
 
List of Abbreviations         xii 
 
Abstract          1 
 
Chapter 1: Introduction        6 
 
Introduction and the study of molecular interactions     6 
 
Backscattering Interferometry as an analytical tool     14 
 
Previous BSI experiments        24 
 
Origin of BSI signal         28 
 
Overview of Doctoral Research       35 
 
References          39 
 
Chapter 2: BSI as an ultrasensitive method for unperturbed detection of 
Acetylcholinesterase Inhibitor interactions     43 
 
Introduction          43 
 
Materials and Methods        51 
  
Results and Discussion        57 
 
Conclusion          68 
 
References          70 
 
 
 
 
 
 vii 
Chapter 3: Detection of various single nucleotide polymorphisms in short dsDNA 
sequences          73 
 
Introduction          73 
 
Materials and Methods        79 
 
Results and Discussion        82 
 
Conclusion          95 
 
References          99 
 
Chapter 4: Potassium Ionophore studies with BSI and evaluation of FreeSRF in 
nonaqeuous, small molecule, ion-recognition systems    102 
 
Introduction          102 
 
Materials and Methods        110 
 
Results and Discussion        114 
 
Conclusion          128 
 
References          131 
 
Chapter 5: Conclusions and Future Work      134 
 
Determining stoichiometry from BSI binding experiments    137 
 
Observing decomplexation with BSI       141 
 
Future work with BSI         142 
 
Concluding remarks         144 
 
References          146 
 
 
 
Vita           147 
  
 viii 
 
List of Figures 
Figure 1.1. Schematic of SPR. 
Figure 1.2. Schematic of ITC. 
Figure 1.3. Constructive and destructive interference. 
Figure 1.4. Young’s double-slit experiment. 
Figure 1.5. Schematic of interferometers. 
Figure 1.6. Schematic of MIBD. 
Figure 1.7. Optical ray trace of laser light in microfluidic chip. 
Figure 1.8. Schematic and photograph of BSI. 
Figure 1.9. Probe volume of semi-circular chip channels. 
Figure 1.10. Examples of good and bad fringe patterns. 
Figure 1.11. Image of BSI data collection screen. 
Figure 1.12. BSI calibration curve of phase shift vs. glycerol concentration. 
Figure 1.13. Binding curve and diagram of Ca
2+
 binding to CaM. 
Figure 1.14. Binding curves and conformational change of Ca
2+
/CaM to ligands. 
Figure 1.15. Experimental and modeled binding curves to evaluate FreeSRF. 
Figure 2.1. Acetylcholine’s cycle as a neurotransmitter. 
Figure 2.2. Diagram showing active sites of AChE. 
Figure 2.3. Silanization of channel walls with MEPTES. 
Figure 2.4. Binding curve of AChE with edrophonium. 
Figure 2.5. Binding curve of AChE with propidium. 
Figure 2.6. Binding curve of AChE with galantamine. 
Figure 2.7. Binding curve of AChE with BW284c51. 
Figure 2.8. Binding curve of AChE with physostigmine. 
Figure 2.9. Binding curve of AChE with Ligand 1. 
Figure 2.10. Binding curve of AChE with Ligand 2. 
Figure 2.11. Binding curve of AChE with Ligand 3. 
Figure 2.12. Binding curve of AChE with Ligand 5. 
Figure 2.13. Binding curve of AChE with Ligand 4 and inset. 
 ix 
Figure 2.14. Binding curve of AChE with Ligand 6. 
Figure 3.1. Traditional Watson-Crick base pairs. 
Figure 3.2. Order of stabilities of DNA base pairs. 
Figure 3.3. Calibration curve of complement duplex DNA. 
Figure 3.4. Binding curve of complement duplex. 
Figure 3.5. Binding curve of Quarter T deletion duplex. 
Figure 3.6. Binding curve of Quarter AG mismatch duplex. 
Figure 3.7. Binding curve of Middle T deletion duplex. 
Figure 3.8. Binding curve of Middle AG mismatch duplex. 
Figure 3.9. BSI signal plot of nonsense strand. 
Figure 3.10. Melting profiles of DNA duplexes. 
Figure 3.11. Comparison of BSI KD to Tm of complement and deletion SNPs. 
Figure 3.12. Comparison of BSI KD to Tm of complement and mismatch SNPs. 
Figure 3.13. Melting absorbance profile of middle AG mismatch. 
Figure 3.14. Possible structures of the A/G mismatch pair. 
Figure 3.15.  Binding curves obtained with BSI for each DNA duplex. 
Figure 4.1. Dibenzo-18-Crown-6 and Complex of 18-Crown-6 and K
+
. 
Figure 4.2. Valinomycin structure and depsipeptide components. 
Figure 4.3. Structure of valinomycin-K
+
 complex from DFT simulations. 
Figure 4.4. Bis(benzo-15C5) example and “clamshell” binding. 
Figure 4.5. Potassium Ionophore II and Potassium Ionophore III. 
Figure 4.6.  ITC curve of 10.00 mM 18C6 into 1.00 mM KI. 
Figure 4.7.  ITC curve of 10.0 mM Potassium Ionophore II into 1.00 mM KI. 
Figure 4.8. ITC curve of 2.0 mM KI into 0.2 mM Potassium Ionophore III. 
Figure 4.9. ITC curve of 2.0 mM KI into 0.20 mM Potassium Ionophore I. 
Figure 4.10. BSI binding curve of 18C6 with KI.   
Figure 4.11. BSI binding curve of Potassium Ionophore II with KI.   
Figure 4.12. BSI binding curve of Potassium Ionophore I (Vm) with KI.   
Figure 4.13. BSI binding curve of Potassium Ionophore III with KI. 
Figure 4.14. BSI binding curve of 18C6 with NaI.   
 x 
Figure 4.15. BSI binding curves of complementary dsDNA and VmK
+
. 
Figure 4.16. BSI binding data of Na
+
 with 18C6, K
+
 with 18C6, and K
+
 with 
ionophore II. 
Figure 4.17. Structures of calculated lowest-energy conformations of free 18C6. 
Figure 4.18. Free 18C6 in the S6 and Ci conformation compared to 18C6K
+
 complex. 
Figure 4.19. BSI binding curves of phase shift vs molar ratio of K
+
 for ionophores II 
and I. 
Figure 4.20.  Modeled structure of bound potassium ionophore II. 
Figure 4.21. Depiction of differences between experimental and modeled χ values. 
Figure 4.20. 3D Stick model of free potassium ionophore III. 
Figure 5.1.  Phase shift vs. Molar Ratio of complement DNA duplex. 
Figure 5.2.  Phase shift vs. Molar Ratio of potassium ion to ionophore I. 
Figure 5.3.  Phase shift vs. Molar Ratio of TMAB to DNPU. 
Figure 5.4.  Phase shift vs. Molar Ratio of Ca
2+
 to CaM. 
Figure 5.5. Simulation of the decomplexation of the VmK
+
 complex with water. 
Figure 5.6. Phase Shift vs. Molar Ratio of water to VmK
+
 BSI data. 
Figure 5.7. Structure of staphylopine. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 xi 
List of Tables 
Table 1.1. KD results of free-solution and surface-immobilized BSI experiments. 
Table 1.2. Comparison of χexp and χmodel to evaluate the FreeSRF expression. 
Table 2.1. Known inhibitors used for BSI experiments in PBS. 
Table 2.2. Novel inhibitors used for BSI experiments in PBS:MeOH (9:1). 
Table 2.3. Comparison of BSI KD/Ki values to literature KD values. 
Table 2.4. BSI Ki/KD values compared to Ellman IC50 values. 
Table 3.1.  List of DNA oligonucleotides. 
Table 3.2. BSI KD values of oligomer duplexes. 
Table 3.3. Tm of duplexes compared to BSI KD values. 
Table 3.4.  KD, Bmax, and χexp values of DNA duplexes. 
Table 4.1. Crown ether structures and coordinating cation. 
Table 4.2. BSI and ITC results of TMAB complexes with ureas and thioureas. 
Table 4.3. χexp and χmodel of ionophores. 
  
 xii 
 
List of Abbreviations 
 
15C5    15-crown-5 
18C6    18-crown-6 
A    Adenine 
ACh    Acetylcholine 
AChE    Acetylcholinesterase 
AChEI    acetylcholinesterase inhibitor 
AD    Alzheimer’s disease 
ATCh    Acetylthiocholine 
Aβ    Beta amyloid 
BChE    Butyrylcholinesterase 
bp    Base pair 
BSI    Backscattering Interferometry 
C    Cytosine 
CaM    Calmodulin 
CaN    Calcineurin 
CCD    Charge-coupled device 
CD    Circular dichroism 
ChAT    Choline acetyltransferase 
Cy3    Cyanine-3 
DMSO    Dimethyl sulfoxide 
DNA    Deoxyribonucleic acid 
DNPTU   Dinitrophenyl thiourea 
DNPU    Dinitrophenyl urea 
DPTU    Diphenyl thiourea 
DPU    Diphenyl urea 
dsDNA   Double-stranded DNA 
DTNB    Dithionitrobenzoic acid 
FFT    Fast Fourier transform 
FITC    Fluorescein isothiocyanate 
FLIM    Fluorescence lifetime imaging microscopy 
FRAP    Fluorescence recovery after photobleaching 
FreeSRF   Free-solution response function 
FRET    Fluorescence resonance energy transfer 
G    Guanine 
GPCR    G-protein coupled receptors 
HBOC    Hereditary breast and ovarian cancer 
ISE    Ion selective electrode 
 xiii 
ITC    Isothermal titration calorimetry 
LIGO    Laser Interferometer Gravitational-Wave Observatory 
LOD    Limit of detection 
M13    Myosin light chain kinase peptide 
MB    Molecular beacon 
MeCN    Acetonitrile 
MeOH    Methanol 
MEPTES   3-mercaptopropyltriethoxysilane 
MIBD    Micro-interferometric backscatter detector 
mRec    Myristoylated recoverin 
NMR    Nuclear Magnetic Resonance 
PAS    Peripheral anionic site 
PBS    Phosphate-buffered saline 
PCR    Polymerase chain reaction 
PDB    Protein databank 
Rgyr    Radius of gyration 
RI    Refractive index 
RIU    Refractive index units 
RNA    Ribonucleic acid 
RU    Resonance units 
SAR    Structure-activity relationship 
SASA    Solvent accessible surface area 
SEM    Standard error of the mean 
SNP    Single nucleotide polymorphism 
SPR    Surface Plasmon Resonance 
ssDNA   Single-stranded DNA 
T    Thymine 
Tfp    Trifluoperazine fluoride 
TMAB    Tetramethylammonium benzoate 
UV    Ultraviolet 
Vm    Valinomycin 
XMEA   X-linked myopathy with excessive autophagy 
 
 
 
 
 
 
Abstract 
 
 Back-scattering Interferometry (BSI) is an analytical technique that measures 
changes in refractive index (RI) as two species interact in solution.  A high-contrast 
interference fringe pattern is generated, and the fringes shift spatially as molecular 
interactions such as binding occur.  Experiments can be performed label-free in free 
solution, eliminating the potential perturbations that can arise with surface 
immobilization or fluorescent labeling.  The source of this signal change derives from 
intrinsic property changes as a new species, the complex, is formed in solution, 
particularly changes in conformation and solvation.  Recently an expression for the 
source of this signal, the Free Solution Response Function (FreeSRF) was developed in 
an effort to more fully describe and quantify it.
1
  A binding curve is generated from the 
data, from which dissociation constants can be determined for a measure of binding 
affinity.  The work in this dissertation covers three different types of binding systems 
analyzed with BSI. 
 First, a series of known and novel inhibitors of acetylcholinesterase (AChE) were 
screened, the former to benchmark the technique and the latter to evaluate potential anti-
Alzheimer’s disease (AD) agents.  By comparing KD results from BSI to IC50 values 
obtained using Ellman’s assay,2 insight into the inhibition mechanism for each inhibitor 
could be obtained based on the Cheng-Prusoff relationship.
3
  Specifically, BSI KD values 
that were equal to Ellman IC50 indicated the inhibitor was acting via noncompetitive 
inhibition, while inhibitors with KD < IC50 acted as competitive or mixed inhibitors.  
These results make BSI an especially good technique for evaluating potential anti-AD 
agents that act as noncompetitive inhibitors and target the peripheral site of the enzyme, 
 2 
where beta amyloids are known to aggregate and accelerate plaque formation.
4
  
Additionally, using a high-affinity inhibitor, BW284c51, we showed that BSI is capable 
of detecting less than 23,000 AChE molecules at the lowest limit, a level that matches or 
exceeds detection limits of other techniques.
5,6
 
 Next, we evaluated BSI’s ability to distinguish between several 20-base pair DNA 
oligomers: a perfect complement and a sequence containing a SNP.  The SNP-containing 
sequences had either a mismatch or a deleted base located in the middle of the sequence 
or five base pairs from the 3’-end. By comparing the BSI KD values of each duplex and 
comparing those to melting transition temperatures obtained from hyperchromicity 
experiments, we confirmed our hypothesis that the complement duplex was significantly 
more stable than any of the duplexes containing a SNP, having a KD ca. 18-130% lower 
than the SNP duplexes.  Additionally, SNPs located in the middle of the sequence were 
more destabilizing than the same SNP located closer to the end of the sequence, and 
when comparing two different SNPs at the same location, the A/G mismatch was more 
destabilizing than the T deletion.  The complement duplex also had at least a 35% larger 
signal compared to the SNP duplexes.  SNP research is an important field for 
personalized medicine and disease diagnostics, and this work showed BSI could play a 
role in advancing those fields. 
 Lastly, BSI was used to detect selection ion recognition of 18-crown-6 and three 
ionophores to potassium.  These small molecules in nonaqueous media were expected to 
produce a much smaller signal compared to the large biochemical systems typically 
studied with BSI due to a lack of major conformation and solvation changes as seen with 
protein binding or DNA hybridization. Experiments with ITC benchmarked the BSI 
 3 
results.  The goal was to quantify the smallest possible signal BSI could detect and 
evaluate the FreeSRF expression for nonaqueous, small molecule systems.  Formation of 
potassium complexes with potassium ionophores I and II generated signals more than an 
order of magnitude smaller than complement DNA hybridization.  Potassium ionophore 
I, also known as valinomycin, folds into a “tennis ball seam” conformation upon binding 
with potassium while potassium ionophore II forms a “closed clamshell” structure; these 
complexes generated a signal over 30% larger than that of the potassium-18C6 complex, 
which undergoes only a minor shift in conformation from a S6 or Ci
 
structure to D3d upon 
complexation.
7,8
  Conversely, Na
+
 with 18C6 experiments generated no readable signal 
above the noise, highlighting BSI’s ability to selectively detect ion recognition. 
 Interesting observations into the direction of the signal were also made, 
particularly with ionophore III, which features a dodecyl tail in the middle of the linker 
between the two 15C5 ends and caused the signal to reverse direction as potassium was 
added.  Signal direction is thought to be related to hydrodynamic radius, which this 
hydrocarbon tail would significantly alter as the ionophore forms the “closed clamshell” 
complex.  Other experiments show BSI has potential to examine the stoichiometry of 
binding systems, and decomplexation, rather than complexation, of the ionophore I-
potassium complex in water. 
 BSI offers many advantages compared to other techniques, including its ability to 
run experiments label-free and in free solution, its small sample size (with a probe 
volume of just 7.52 nL), and high sensitivity even in small-molecule systems with very 
minor conformational changes.  These experiments show it has potential for many uses, 
from diagnostics, drug screening, and metal ion detection.  As research into the signal 
 4 
origin and FreeSRF evaluation progress, it will continue to be a valuable refractive index 
detector for various chemical fields. 
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Chapter 1: Introduction 
1.1 Introduction and the study of molecular interactions 
Chemical interactions are ubiquitous in life, and a wide variety of assays exist to 
study just a small portion of these reactions, interactions, and functions.  Analytical 
techniques have allowed for significant discoveries and progress in biochemical, 
medicinal, and chemical fields and have grown increasingly sensitive and powerful over 
the past few decades.  Both inter- and intramolecular forces, including hydrogen bonds 
and London dispersion, are responsible for inducing changes to chemical systems, from 
simple hydrogen bonds in water to the complex interactions in protein folding.  
Measurements of these systems are obtained by a variety of techniques, each with 
specific advantages, but occasionally disadvantages as well.   
1.1.1 Analytical techniques for measuring chemical interactions 
 The understanding of chemical interactions, particularly binding interactions, is 
vitally important for a variety of chemical fields, from mechanistic studies to drug 
discovery.  Analytical techniques designed for measuring such interactions can typically 
be divided into three categories: 1) fluorescent techniques, 2) surface-immobilized 
techniques, and 3) free-solution techniques.  Each has a unique set of strengths and 
drawbacks. 
 Fluorescence assays, where a fluorescent probe is the source of a signal, are 
commonly used for many biochemical systems both in vitro and in vivo.  They make use 
of a fluorophore’s ability to emit a photon of light upon excitation of electrons.  There are 
several techniques and methods used to image and measure fluorescence, including 
 7 
fluorescence resonance energy transfer (FRET), which measures energy transfer between 
two fluorophores based on their distances from each other; fluorescence recovery after 
photobleaching (FRAP), which allows for a measure of diffusion through cells; and 
fluorescence lifetime imaging microscopy (FLIM), which measures fluorescence based 
on its lifetime rather than intensity like most other methods.
1
  Fluorescence 
characteristics that must be considered for experiments include the quantum yield, a 
measure of brightness or the ratio of photos emitted to absorbed; fluorescence lifetime, 
which determines how long an electron exists in the excited state; anisotrophy, a measure 
of the orientation of the fluorophore’s transition dipoles, which must be aligned to the 
polarization of the excitation light; and any possible quenching or photobleaching, or 
decreasing or interruption of fluorescence.       
 Early fluorescence studies starting with fluorescence microscopes date back over 
100 years, but early instruments suffered from inadequate light sources.  Fluorescence 
assays today produce some of the lowest detection limits available with high sensitivity 
in straightforward assays, including at the single-molecule level for a variety of 
biochemical targets.
2,3
  The main disadvantages of these assays are the requirement of 
lengthy procedures to label, and the risk of interfering with the target’s natural binding 
affinity or mechanism.
4
   
 Surface immobilized techniques, such as surface plasmon resonance (SPR), 
require tethering one analyte to a surface for measurements, and have the advantage of 
performing experiments in real-time and label-free.  In SPR, a glass chip with a metal 
(usually gold) film is used as the surface.  Analytes are tethered to the metal film, and 
their ligands are introduced in solution through a flow channel.  Polarized light is directed 
 8 
onto the glass chip with a prism.  As light strikes the surface of the chip at a certain 
incidence angle, an evanescent wave is generated which interacts with the electrons in the 
metal layer to generate the plasmons (movements, or oscillations, of electron density), 
reducing the intensity of the reflected light.  The resonance angle can be measured based 
on where the lower-intensity light is detected, and this angle is based on the refractive 
index of the channel solution.  When analytes bound to the surface of the metal interact 
and bind with the analytes flowed through the system, the refractive index at the surface 
changes, so the angle at which the incident light generates plasmons changes, and the 
intensity of light increases at the initial angle.  Binding kinetics can be determined from 
experiments.
5
 
 Many biochemical systems have been examined with SPR, including DNA, RNA, 
proteins, lipids, cells, and potential drug candidates.
5
  A schematic of SPR is shown in 
Figure 1.1.  Like fluorescence techniques, sample preparation (namely surface 
immobilization) can perturb natural binding affinity, particularly for interactions 
occurring near the surface, as will be discussed in Section 1.3.
6
     
 
Figure 1.1. Schematic of SPR.  As binding occurs at the surface, the dark spot of the 
reflected light shifts.
7
 
 
Free-solution techniques such as nuclear magnetic resonance (NMR) or 
isothermal titration calorimetry (ITC) require no additional labeling or surface 
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preparation.  ITC is a free-solution thermodynamic technique which measures heat 
released or absorbed against a reference cell, as one species is titrated into another, by 
measuring the power required to maintain an equal temperature between the cells.  This 
technique is often used with biochemical systems, and one of its main advantages is its 
ability to provide a complete thermodynamic profile with one experiment, including 
stoichiometry (n), binding association (Ka), and enthalpy and entropy changes (∆H and 
∆S, respectively).  Repeat experiments at different temperatures allow for the binding 
heat capacity, ∆Cp, to be calculated.
8
  
To ensure proper reference and temperature matching, the reference cell must 
contain the same, degassed solvent or buffer as the analytes in the sample cell and 
syringe.  Large background heats of dilutions must occasionally be accounted for, though 
these are usually negligible.  An approximation of the concentration ranges to use is 
based on the Ka of the complex formed; the product of the Ka and concentration C of 
analyte in sample cell is equal to the Wiseman Constant, which should be less than 200.  
The syringe concentration should be at least seven times higher, or 7n for stoichiometries 
where n > 1, to ensure adequate saturation of the binding isotherm.  Figure 1.2 shows a 
diagram of the instrument. 
 10 
 
Figure 1.2. Schematic of ITC.  The inner jacket and outer shield help control the 
temperature.  The syringe injects analyte into the sample cell while the mixing needle 
spins at a constant rate to ensure equilibration. 
 
These techniques’ main disadvantage is that typically higher concentrations and 
volumes are required compared to other methods, on the order of several mLs and 
millimolar concentration as opposed to nanomolar or micromolar.  These conditions can 
be especially disadvantageous since high concentrations can lead to analyte aggregation 
in some systems.  Automated versions of ITC with significantly scaled-down volumes are 
in development, with the main challenge being their sensitivity.
8
  
1.1.2 Interferometry as an analytical technique 
Interferometry was first developed in the 1800’s with Young’s double-slit 
experiment.  In this experiment, he observed the way light behaves when it is directed 
through two pin holes to form two separate waves, which interact constructively and 
 11 
deconstructively.
9
  It also was the first experiment to demonstrate light’s wave-like 
behavior.   
Constructive Interference 
 
Destructive Interference 
 
Figure 1.3 Constructive and destructive interference. 
 
In constructive interference, two waves with identical amplitude, frequency, and 
phase combine to create a wave with twice the amplitude.  Conversely, with destructive 
interference, the waves have the same amplitude and frequency, but opposite phases, so 
when combined they cancel each other out.  These two phenomenon are shown in Figure 
1.3 as a combination of sine and cosine waves.  A schematic of Young’s interferometer is 
depicted in Figure 1.4.   
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Figure 1.4. Young’s double-slit experiment generating an interference fringe pattern.10 
 
A combination of constructive and deconstructive interference of light results in 
an interference fringe pattern, where each ‘fringe’ is a bright spot, generated by 
constructive interference, separated by dark spots resulting from destructive interference.  
Thus, interferometry is the study of waves (usually light/electromagnetic) and the 
materials with which the waves interact. 
While Young’s double-slit experiment generated a fringe pattern based on light 
diffraction, interference fringe patterns can also be generated by light refraction, based on 
differences in the refractive index (RI) of materials being examined.  The refractive index 
(η) is the ratio of the speed of light in a vacuum (c) to the speed of light through a given 
material, such as water or glass (v).  Instruments that measure interferometry are known 
as interferometers, and several different types exist for different analytical purposes both 
within chemical fields and beyond, from seismology to astronomy. 
 One of the earliest interferometers, which dates to the late 1800’s, is the 
Michelson Interferometer.  It uses a single light source, a beamsplitter or half-silvered 
 13 
mirror, and two mirrors to direct the split beams back to the beamsplitter, where they are 
recombined.  The interference pattern resulting from their recombination is directed onto 
a detector.  Another interferometer, most often used to measure the RI of gases, was the 
Rayleigh interferometer.  In this design, a collimated light source was split into two 
beams, with each directed through cells or tubes, one of which contained the target gas.  
The beams were then recombined using a lens, and their interference fringe pattern could 
then be analyzed.  One drawback to this simple design, however, is the high 
magnification needed to observe the fringes.  Another example is the Mach-Zehnder 
interferometer, which also dates back to the 1890’s and uses two beamsplitters and two 
mirrors to divide and recombine the light.  It was typically used to study heat transfer, 
fluids, and plasmas.
11
  Figure 1.5 depicts the basic set-up for these examples of 
interferometers. 
 
Figure 1.5.  Schematics of interferometers, with the mirrors or lenses in blue and the red 
line representing the path of the light beams. A) Michelson Interferometer with one 
screen, B) Mach-Zehnder Interferometer with two detectors, and C) Rayleigh 
Interferometer, where one of the tubes would be filled with gas/gas mixture for analysis. 
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Interferometers have been used to make a variety of measurements at both the 
micro and macro scale, including measuring the radii of celestial objects,
12
 evaluating the 
quality of lenses or mirrors,
13
 imaging ocean currents,
14,15
 and biosensing.  A type of 
Mach-Zehnder interferometer was used as a biosensor beginning in 1993, and had the 
advantage of minimizing temperature-related drift due to the two pathways containing a 
reference and a sample that could be measured simultaneously.
16
  Most recently at the 
macro scale, a modified Michelson Interferometer at the Laser Interferometer 
Gravitational-Wave Observatory (LIGO) confirmed the existence of gravitational waves 
predicted in Einstein’s theory of general relativity.17    
1.2 Backscattering Interferometry as an analytical tool 
1.2.1 Development of the backscattering interferometer 
 BSI began as a refractive index detector for liquid chromatography separations in 
the late 1990s, and evolved to fit a growing need for highly sensitive, miniaturized 
platforms.  Initially known as micro-interferometric backscatter detection (MIBD), it was 
shown by Darryl Bornhop to be a universal detector capable of measuring changes in 
refractive indices at small volumes, with a probe volume of ca. 1.2 nL, and high 
sensitivity, with a detection limit refractive index change of ca. 10
-7 
RIU.  A 1999 study 
reported it was able to detect four different solutes (NaCl, phenol, toluene, and 
ethylbenzene) in a mixture at ppm levels.
18
  This precursor used a capillary mounted on a 
stage rather than a chip, where the monochromatic laser light could impinge 
perpendicular to the capillary to generate the backscattered interference fringe pattern, as 
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shown by the diagram in Figure 1.6.  Alignment of the setup was tedious, and only one or 
two fringes’ intensities and positions could be measured at a time by the detector.  
 
Figure 1.6. Schematic of MIBD setup.
18
 
 
By 2000, the Bornhop group had developed a chip-scale version of the 
backscatter detector that was used with capillary electrophoresis, which provided 
detection limits of 10
-6
 RIU for solutions.
19
  The etched channels in a glass chip allow for 
a multipass optical configuration, which allows for the light to pass through the sample 
several times and increases the effective path length to lower the detection limit, as 
shown in the optical ray trace in Figure 1.7.  
 
Figure 1.7. Optical ray trace showing the laser light entering the chip and passing 
through multiple times before exiting.
20
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The instrument used in this thesis is shown in Figure 1.8.  The microfluidic chip 
containing the analytes is secured to a translational stage for proper alignment.  A helium 
neon (HeNe) laser is directed via fiber optic couple to a mirror above the stage, aligned 
so the light impinges the chip perpendicularly.  The light interacts with the analytes in the 
chip’s channel and is backscattered by the mirror to a charge-coupled device (CCD) 
detector.  A density filter prevents the intensity of the light from overpowering the 
detector.  Since RI is temperature dependent, with a particularly high dη/dT for liquids (1 
x 10
-4
 °C in H2O), the stage is temperature-controlled via a peltier device, thermistor, and 
aluminum heat sink.  In most experiments, the stage is heated to 25 °C.  Solutions are 
injected via pipette into one well of the channel, and vacuumed out the opposite well 
prior to introduction of the next sample.  
 17 
 
Figure 1.8.  A) Schematic of BSI with a sample fringe pattern as seen on the detector.
21
 
B) Photo of BSI setup. 
 
1.2.2 Microfluidic glass chip 
 Analytes (receptor and ligand) are injected into channels within a borosilicate 
glass chip (η = 1.52) for analysis with BSI.  The chip contains three parallel, semicircular 
Detector 
HeNe laser 
Stage/Heat Sink 
Mirror 
Fiber Optic 
Density Filter 
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channels etched into the glass which feature hydrophilic walls when untreated.  Surface 
treatments, typically silanization, can be used to functionalize the channel walls and 
render them hydrophobic.  Silanization is usually necessary for charged biological 
systems, including two of the studies featured in this thesis.   
Initially, the channels in the chips were 90 μm wide, and the probe volume, that 
is, the volume of solution within the channel hit with the laser light, was ca. 360 pL.  
Presently, the chips now feature wider channels, with a 210 μm width, and a 7.52 nL 
probe volume.  Figure 1.9 depicts how the probe volume is determined.  The wider width 
and larger probe volume allows for more signal generation due to the increased volume 
of analytes being interrogated by the laser light at a given time.  It also helps decrease 
clogs in the channels due to a build-up of residues from repeated use, particularly with 
the silanization solutions (one of which is a saturated potassium hydroxide (KOH) 
solution in methanol, which tends to evaporate readily at the small volumes used for the 
procedures). 
 
Figure 1.9.  Probe volume of the semi-circular channels within the microfluidic chip, 
where r = 100 μm, w = 10 μm, and l = 450 μm (the diameter of the laser beam). 
 
 The chips generally last for two to three years before wear can be seen along the 
channels under a microscope for unsilanized chips, and for chips that are frequently 
functionalized this lifetime is considerably shorter, on the order of about a year.  They are 
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cleaned by rinsing with water and sonication for short periods of time (usually 30 min).  
Clogs can usually be cleared by short soaks with concentrated nitric acid; more severe 
clogs or build-up along the walls may require a dilute piranha solution (H2SO4 and H2O2) 
or a dilute Contrad 20 solution soak for 1-2 min.  Clogs in the channels are best avoided 
by frequent rinsing, and avoiding evaporation during procedures that require longer 
soaking in solutions.  
1.2.3 Data acquisition 
 Real-time measurements are obtained by the computer with a fast Fourier 
transform (FFT) analysis of the fringes that appear on the CCD detector.  Typically six 
fringes are analyzed by the detector.  Fringe selection is vital; the fringes must be a 
certain distance away from the centroid, and have high contrast, Gaussian or sigmoidal 
shape, and low noise.  Background light must also be avoided, so experiments are done in 
the dark.  Figure 1.10 compares a good fringe pattern to a few examples of poor fringe 
patterns. 
 
Figure 1.10.  A) A good fringe pattern, with high-contrast, Gaussian-shaped peaks of 
similar size and shape. B) A poor fringe pattern, with noisy peaks of inconsistent sizes.  
C)  A fringe pattern with an intensity that’s maxing out the detector due to too high an 
integration time.  D) A fringe pattern that is affected by background light. 
 
 Proper alignment of the components (laser, mirror, chip, and detector) is also 
essential for successful experiments.  Parallel rays of the laser beam should evenly 
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impinge the channel perpendicularly, so that the fringes (bright spots) on either side of 
the centroid have equal intensities.  Additionally, examination of the optical ray trace 
(Figure 1.5) reveals that not all fringes originate from the same spot on the chip; some are 
nearer to the surface or edge of the channel, thus these would report a weaker free-
solution signal compared to those originating from the central part of the channel (where 
most of the energy, or rays, would be directed).  The FFT of the fringes in the desired 
region (typically around fringes 6-14 from the centroid) generates a nearly single spatial 
frequency; a pure single frequency is not obtained due to signal mixing from the rays that 
interrogate portions of the solution nearer the surface or edges.  This measured frequency 
remains constant as the fringes shift spatially upon RI changes, and the LabView 
software used for data collection displays both the fringes and the FFT in real time, as 
shown in Figure 1.11. 
 
Figure 1.11. Data collection screen, with the fringes (top), FFT with a large, nearly-
single frequency peak (middle), and phase collection (bottom). 
 
To ensure that the signal being measured is a result of only the desired interaction, 
and not concentration-dependent effects, or background or buffer interactions, reference 
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solutions must be made to match with each sample binding solution, where the only 
difference between the reference and sample is the presence of the receptor.  These can 
then be subtracted from the signal during data analysis.  Similarly, surface interactions 
must be minimized, so silanization or other functionalization of the channel walls may be 
necessary.  Repeated injections of buffer after each trial check the signal’s return to the 
established baseline to ensure that surface adsorption is not causing a spurious signal.  
Keeping these factors in mind when designing experiments, it is possible to measure 
binding even in complex media such as serum.
22
 
 
1.2.4 BSI Calibration and limits of detection 
The BSI is calibrated with a series of glycerol solutions in water at increasing 
concentrations.  The signal of each sample is plotted versus the concentration.  A linear 
dη/dC relationship is observed, as depicted in Figure 1.12, and a minimum of three trials 
are performed in order to determine the standard deviation of the signal.   
 
Figure 1.12. BSI signal versus glycerol concentration calibration curve. 
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To ensure a high level of confidence in the detection limit, 3σ statistics is used.  
The detection limit of the instrument can then be calculated in terms of either refractive 
index units (RIU, η) or concentration (C) in mM with Equations 1 and 2:  
     
  
  
 
  
     
       (1) 
          
  
   
         (2) 
where LOD is the limit of detection, σ is the standard deviation, m is the slope of the 
signal vs concentration line, and dη/dCgly is the change of RI with a change of glycerol 
concentration, a given value that can be found in references such as the CRC 
Handbook.
23
  When calibrating the BSI, acceptable target values for the limit of detection 
(LOD) in RIU is on the order of 10
-6
 RIU, and in concentration of glycerol is < 2.0  mM.  
Additionally, because the instrument is exposed, environmental conditions can disrupt 
measurements, so stable room temperature, pressure, and humidity are vital. 
1.2.5 Data analysis 
 The binding of two species essentially creates an entirely new, unique species 
with a new, unique RI, which causes a significant signal change.  Specifically, changes in 
conformation, solvation, polarizability, etc contribute to the signal changes, the details of 
which will be discussed in Section 1.4.  The two species are referred to as a receptor and 
a ligand.  A dissociation constant (KD) can be calculated from steady-state, or endpoint, 
assays by holding the receptor at a constant concentration in a series of samples while 
increasing the concentration of the ligand towards saturation.  Equation 3 shows how the 
KD is calculated from an end-point BSI experiment when plotting signal versus 
concentration of ligand, where x is the concentration of ligand and y is the phase shift.  
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Since Bmax has units of the y-axis at maximum binding, it is the maximum phase shift of 
the product upon reaching its maximal concentration. 
  
      
    
        (3) 
       
         
       
      (4) 
The law of mass action (eq 4) states that the rate of a reaction is proportional to 
the product of the masses of the reactants, in other words, for a reaction mixture at 
equilibrium (such as BSI endpoint experiments), the ratio between the concentration of 
the reactants and concentration of the products remains constant.  Here [R•L]∞ is the 
concentration of the product complex at infinite time (equilibrium), [R]0 is the initial 
concentration of receptor, [L]0 is the initial concentration of the ligand, and KD is the 
dissociation constant.  The KD of a system is the inverse of the association constant, Ka, 
determined with instruments such as ITC.  This allows for a comparison of BSI results to 
other techniques, and also means that a lower KD is indicative of a stronger affinity in a 
given system with the same receptor and various ligands. 
 When designing BSI experiments, it is important to work in concentration ranges 
that generate a measurable phase shift from the product formed while avoiding 
concentrations that are too high that the dη/dC of the product is above the noise level.  A 
general rule of thumb for determining acceptable ranges are receptor concentrations of 
approximately KD/10, and ligand ranges spanning at least two to five times higher in 
order to reach saturation.  If the KD is unknown, ranges may be approximated by running 
a dη/dC experiment, similar to the glycerol calibration, of serially diluted samples of 
product. 
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1.3 Previous BSI experiments 
1.3.1 Protein binding with various ligands 
 Various protein binding interactions have been studied with BSI in the past 
decade.  A good example is Calmodulin (CaM), a calcium-selective messenger protein, 
with several ligands.
24
  Upon binding with four Ca
2+
 ions, CaM undergoes a significant 
conformational change, as depicted in Figure 1.13A.  The binding curve produced from 
free solution BSI experiments of CaM with Ca
2+
 is shown in Figure 1.13B.  It was 
hypothesized that the significant conformational change of the protein was the main 
source of the large signal. 
 
Figure 1.13. A) BSI binding curve of CaM with Ca
2+
.
25
 B) Conformational change that 
occurs in CaM when four calcium ions are bound.
26
 
 
 CaM undergoes another conformational change when its Ca-bound form interacts 
with another ligand.  There are a wide range of potential targets, and the ligands included 
in this study were trifluoperazine fluoride (Tfp), a small molecule; a 17-residue peptide 
known as myosin light chain kinase peptide (M13); and the protein calcineurin (CaN).  
Each ligand resulted in a measurable binding curve and calculated KD values.  Binding 
curves and a representative conformational change are shown in Figure 1.14.  
A B 
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Figure 1.14. A) BSI binding curve of CaM/Ca
2+
 with small molecule Tfp. B) BSI 
binding curve of CaM/Ca
2+
 with M13 peptide.
25
 C) Conformational change that occurs 
when CaM/Ca
2+
 binds with a small peptide or ligand.
26
 
 
1.3.2 A direct comparison of free-solution and surface-tethered interactions 
 When designing analytical assays for biochemical systems, ideal conditions 
would be physiologically relevant in terms of temperature, concentration, and the form of 
the analytes. Many analytical techniques rely on fluorescence labeling or surface 
tethering of one analyte.   While these actions provide a way to obtain a desirable signal, 
several studies have shown that they can also impact binding affinity.  Several studies 
involving fluorescently-labeled DNA showed that, depending on the structure or 
sequence of a DNA strand, the fluorophore could stabilize its hybridization to a 
A B 
C 
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complementary strand or alter the equilibrium by changing the thermodynamics of the 
system.
27,28
 
 Surface immobilization can also have an effect on binding, particularly if the 
binding interaction occurs close to the surface due to changes in the chemical 
environment as well as steric effects.  For example, this was shown to have a significant 
impact on DNA hybridization as a consequence of the charged phosphate backbone.
29
  
Melting studies, kinetic assays, and other techniques were developed in an attempt to 
quantify the amount of perturbation caused by immobilization, but no technique prior to 
BSI was able to yield a direct comparison to untethered measurements at physiological 
conditions.  BSI experiments are typically designed to be conducted in free solution, but 
the ability of the channels in the glass chip to be chemically modified means that it is also 
possible to tether the receptor to the surface and obtain binding data from surface-
immobilized experiments.  Additionally, BSI can also be used to measure binding affinity 
differences between fluorescence-labeled and unlabeled duplexes. 
 The BSI studies used 30-base pair DNA oligonucleotides: a probe strand (Ps) was 
used as the receptor in each experiment, and five different binding strands served as the 
ligand: 1) an unlabeled complement, 2) a fluorescein isothiocyanate (FITC)-labeled 
complement, 3) a cyanine-3 (Cy3)-labeled complement, 4) a terminal CA/AC mismatch, 
and 5) an internal AG/GT mismatch.  Two adjacent mismatched base pairs were also 
expected to have a significant impact on binding affinity.  The effect of various types of 
polymorphisms was expanded in a later study discussed in Chapter 3.  ITC and UV-
hyperchromicity experiments were used to benchmark BSI results.  Fluorescence imaging 
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was used to confirm that surface-tethered DNA strands were not removed when the 
binding strand was rinsed away with buffer.
6
 
 Each of the hybridization experiments were carried out in both free-solution and 
surface immobilized with BSI.  For the surface immobilized experiments, in addition to 
the silanization modification necessary for charged biomolecules, the Ps was tethered to 
the microfluidic chip by an ExtrAvidin-biotin interaction.  ExtrAvidin, a modified 
version of the protein Avidin, was chemically linked to the silanized walls, and the Ps 
was labeled with biotin, a small molecule with very high, specific affinity for ExtrAvidin.  
With BSI, surface immobilized, fluorescence-labeled, and free solution-label free DNA 
hybridization could be measured at the same, physiologically-relevant conditions, and the 
KD values determined from each binding curve provided a direct comparison to binding 
affinity for the first time.  The results of these experiments are shown in Table 1.1.
6
 
Table 1.1. KD results of free-solution and surface-immobilized BSI experiments.
6
 
DNA Strand 
Free-Solution BSI 
KD (nM) 
Surface-
Immobilized BSI KD 
(nM) 
Unlabeled 27.4 + 4.7 66.1 + 8.4 
Cy3-labeled 19.6 + 5.8 41.7 + 6.3 
FITC-labeled 17.4 + 2.9 45.6 + 7.7 
Terminal 
Mismatch 
28.9 + 2.4 60.7 + 7.9 
Internal 
Mismatch 
110.4 + 11.6 132.5 + 16.6 
 
 When comparing the KD’s of each binding strand in free solution vs. surface-
immobilized strands, a clear trend can be seen. The Ps immobilized to the chip perturbs 
binding (increases KD) by ca. 50% in all cases except for the internal mismatch, which 
 28 
was already significantly destabilized compared to the complement.  When comparing 
the KD’s of the unlabeled complement to the FITC- and Cy3-labeled versions, the trend 
observed is a modest decrease in KD, or a stabilization of the duplex.  The results from 
this study were the first instance that the effects from fluorescence tagging or surface 
immobilization could be quantified and directly compared to the unlabeled, free-solution 
experiment using the same instrument and conditions, and demonstrated BSI’s unique 
ability to allow for these direct comparisons.  Others have demonstrated this ability with 
BSI, as well.
30
 
1.4. Origin of the BSI signal 
 Refractive index has a well-established response to changes in concentration and 
temperature, yet there are nearly a decade’s worth of reports of BSI measuring protein 
folding, or interactions with small molecules or ions in free solution, where a readable 
signal is generated with little to no mass change.  Experiments are frequently designed 
where the individual ligands or receptors do not produce a dη/dC signal that is readable 
above the noise level of the instrument separately, but upon binding produce a 
significantly larger, measurable signal.  Therefore changes in the bulk RI of the solution, 
arising from conformational, solvation, and polarization changes, have been attributed to 
the BSI signal obtained during binding events, but a more precise explanation or 
quantification of these effects had been unavailable until very recently.  Using a training 
set of systems tested on BSI over the years and computed structural information from 
sources such as the protein databank (PDB), an expression known as the Free Solution 
Response Function (FreeSRF) was developed by Bornhop and coworkers to describe the 
source of the signal in free solution BSI experiments.
31
  They first compared the 
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technique to another technique that measures changes in RI that were typically attributed 
to dη/dC changes, SPR. 
1.4.1. SPR signals are more than a mass-weighted response 
 Sota and coworkers were the first to question the idea of RI changes being solely 
related to dη/dC effects with SPR, and reported a signal attributed to conformational 
changes of tethered dihydrofolate reductase induced by acid denaturization.
32
  Beginning 
in 2000, other groups reported RI signal changes resulting from conformational changes 
with SPR, as well.  Gestwicki and coworkers identified small-molecule induced 
conformational changes on proteins where a negative ∆RI correlated with a decrease in 
the protein’s hydrodynamic radius, and a positive ∆RI resulted from an increase in 
hydrodynamic radius.  Specifically, they noted a signal resulting from calcium binding to 
tissue transglutaminase of ca. 1000 resonance units (RU), which they attributed to a 
significant change in hydrodynamic radius.  Taking into account just the added mass of 
the calcium ion, in comparison, would only result in an increase of 28 RU.
33
  Similarly, 
they reported a net negative ∆RI resulting from small molecule binding to a protein, 
which would be expected to give a positive ∆RI when only considering the mass-related, 
incremental responses.
33
  
 Despite the evidence, several later reports attributed these observations to 
anomalies or improperly prepared samples,
34–36
 but more studies supporting the argument 
that conformational changes produce free-solution signals continued to emerge.  Koch 
and coworkers noted SPR signals from Ca
2+
 binding to myristoylated recoverin (mRec) 
much higher than expected when only considering the minor mass changes.  Using NMR, 
they identified that unbound mRec had a ‘tense’ (T), or compact, conformation, whereas 
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calcium-bound mRec had ‘released’ (R) conformation that was much more extended and 
open.  Changing from T to R results in an increase in the radius of gyration (Rgyr) and 
solvent-accessible surface area (SASA), and thus the hydration shell is altered, which 
they postulated alters the overall RI of the solution.
37,38
 
 In all of these cases, the signal could be observed despite the background surface 
interactions arising from mass changes on the surface.  With BSI and the availability to 
measure changes in RI in free-solution, it was possible to reduce these competing signals 
and begin developing the hypothesis, and then a model, that free-solution binding events 
can be detected based on changes in conformation and solvation. 
1.4.2. The Free-Solution Response Function 
 The calmodulin system studied by the Bornhop lab and discussed in Section 1.3.1 
was the first system examined in order to determine a model to describe the free-solution 
BSI signal.  Structural information from the PDB of bound and unbound CaM was used 
to estimate the SASA and Rgyr and relate them to the signal phase change.  The 
investigation then expanded to a “training set” of other binding partners to develop the 
Free-Solution Response Function (FreeSRF), an expression that mirror’s Beer’s Law, 
shown in Equation 3. 
            (3) 
 Here, ρ is the phase shift, or FreeSRF signal, in radians, χ is the molar 
refractometry of the product (bound [ligand-receptor] complex) in RIU/M, β is the 
instrument response function in radians/RIU, and C is the product concentration in M.  
The molar refractometry, χ, is an intrinsic property of the species, mirroring the molar 
absorptivity of Beer’s Law.  It accounts for properties such as molecular dipole moment, 
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the dielectric constant, and other parameters that may be altered as a consequence of a 
binding interaction.  Experimental values (χexp) may be calculated for a given species 
based on BSI experiments.  To do so, C must be determined from the mass balance 
equation, and β must be determined for the specific instrument on which the experiment 
is conducted. 
 The mass balance equation relates the KD of a binding system to the concentration 
of free receptor [R], ligand [L], and bound complex ([RL])  as shown below: 
   
      
    
 
      (4) 
Total amounts of receptor and ligand can be defined as follows: 
                       (5) 
                       (6) 
Therefore the equation for KD can be rewritten as follows: 
   
                          
    
 
    (7) 
 This equation can be rearranged to a quadratic to make it possible to solve for 
[RL] by using the quadratic equation (which yields two possible answers, only one of 
which is physically relevant).  This allows for the total concentration of bound product to 
be determined at each point on the binding curve. 
     
                                                          
 
 
   (8) 
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 In order to determine β for a given BSI instrument, glycerol dη/dC calibration 
data are used to obtain the slope of the phase shift vs. concentration of glycerol 
relationship.  This is expressed in radians/mM.  β is expressed in radians/RIU, so a 
conversion factor in RIU/mM for the dη/dC of glycerol is used (obtained from the 
CRC).
23.  For the BSI instrument used for this research, β is calculated as follows: 
  
          
       
  
               
   
  
        
       
   
 
   (9) 
 Since ρ values at the lower concentrations of an end-point assay will have more 
error due to reduced signal-to-noise ratio (S/N), experimental χ values should be 
determined with ρBmax, which is simply where ρ = Bmax from the one-site binding 
equation of the BSI data used to determine the KD.  At the maximum signal, the 
concentration of newly-formed product is approaching that of the receptor concentration; 
the mass-balance equation shows that adding increasingly higher concentrations of ligand 
does not produce a linear increase in product concentration. 
 From the experimentally determined χ values, an expression for modeled χ values 
was developed that included terms for the changes in solvent-accessible surface area 
(∆SASA) and radius of gyration (∆Rgyr) from unbound to bound species, in angstroms 
squared and angstroms, respectively, as shown in equation 10. 
                                                      (10) 
 The aveSASA and aveRgyr is the average of those values based on the number of 
available structures (e.g. from PDB), and A, B, C, D, and E are fitting coefficients.  Rgyr 
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can be calculated from the following expression (11), where r is the position and m is the 
mass of each atom. 
      
                
 
   
   
 
   
 
    (11) 
 Bornhop and coworkers used computational programs (such as Chimera) to 
determine these parameters for several ligand-receptor pairs of which BSI data was 
already available.  They then used regression analyses to determine the coefficients A-E.  
This allowed for a comparison of experimental and computationally-determined results. 
 
1.4.3. Evaluating the fit of the FreeSRF models 
 In order to evaluate the FreeSRF calculations, a training set of a variety of binding 
partners was used to compare experimental and modeled χ and ρ values.  This training set 
included a variety of types of receptors, including proteins (Calmodulin, Carbonic 
Anhydrase II, etc) and antibodies (IL-2 Antibody), and their ligands, including peptides 
(calcineurin), small molecules (glucose, mannose), and metal ions (Ca
2+
).  Comparisons 
of experimental and modeled χ values from a variety of receptor-ligand binding pairs in 
the training set resulted in a decent fit which was further improved by dividing the data 
sets of binding pairs into “large” and “small.”  This division was based on the magnitude 
of the signal, or FreeSRF (ρexp), and χ (generally <100 RIU/M or >>100 RIU/M).  Table 
1.2 lists a few of the receptors and ligands, and a comparison of their experimental and 
modeled χ values. 
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 Table 1.2. Comparison of χexp and χmodel to evaluate the FreeSRF expression.  Training 
set systems are divided into large and small models based on the experimental χ.  Some 
receptors are in both large and small models depending on their binding ligand.
31
 
Large Model   Small Model 
Receptor Ligand 
χexp 
(RIU/M) 
χmodel 
(RIU/M) 
% 
Error 
  Receptor Ligand 
χexp 
(RIU/M) 
χmodel 
(RIU/M) 
% 
Error 
IL-2 Ab Interleukin-2 827,964 823,965 0.5   CaM TFP 75.2 73.6 2.2 
Basigin Rh5 215,777 212,174 1.7   CAII Sulpiride 62 60.2 2.9 
CAII Acetazolamide -57,291 -42,419 26.0   Con A Glucose 2.6 4.6 78.1 
CaM Calcineurin 46,087 37,389 18.9   Rec Ca2+ 78 78.1 0.1 
  
 The results of the Bornhop group’s training set show an overall good correlation 
and low to moderate percent error between χexp and χmodel.  Additionally, the model was 
also able to predict the sign of the signal.   
 The initial training set used to evaluate FreeSRF was acquired first by 
experimental data over several years and instruments by the Bornhop group, and then 
modeled using the FreeSRF expression and the bound complexes’ ∆SASA and ∆Rgyr.  
Next, they sought to use the model to obtain calculated χ and ρ values of two binding 
systems, and then prepare BSI experiments to test the validity. The two systems were 
recoverin with Ca
2+
, a protein-ion binding system, and carbonic anhydrase II with 
dansylamide, an enzyme-inhibitor system.  Figure 1.15 shows binding curves obtained 
from BSI experiments, and from calculating ρ using χmodel
 
at each concentration of ligand 
used in the experiments.  The results correlated well, with a percent difference for χmodel
 
of 0.13% for the recoverin-calcium system, and 18.0% for the carbonic anhydrase-
dansylamide system. 
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Figure 1.15. Experimental (blue) and modeled (green) binding curves for (A) recoverin-
Ca
2+
 and (B) carbonic anhydrase II-dansylamide.
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 These initial results indicate that FreeSRF works as a model to describe the source 
of the signal in BSI, but the Bornhop group acknowledge that more refined expressions 
for FreeSRF can still be developed.  The arbitrarily-assigned ‘large’ and ‘small’ model 
sets could be further expanded, for example with longer, narrower-shaped molecules (e.g. 
nucleic acids) rather than more globular-shaped molecules (e.g. proteins).  Small 
molecule hydrogen-bonding systems have been examined with BSI,
39
 but could also be 
used to refine the FreeSRF expression.  Additional parameters could be included to 
account for more electronic changes, for example in instances of oxidation and reduction.  
The development and refinement of the FreeSRF expression and new BSI experiments 
will continue to help advance fields of biosensing and molecular detection.  
1.5. Overview of Doctoral Research 
 Several different biochemical and chemical systems were designed to demonstrate 
BSI’s versatility, to develop experiments that could be expanded for screening other 
systems or ligands, and to examine the source of the signal and evaluate the FreeSRF 
expression, particularly in nonaqueous media.  All were performed in free solution.  
Chapter 2 describes a study using BSI to measure the affinities of Acetylcholinesterase 
(AChE) and several known and novel inhibitors, and to evaluate their potential as anti-
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Alzheimer’s Disease agents; we hypothesized that values would correlate well with IC50 
values obtained from colorimetric assays and thus highlight the relative ease of BSI 
experiments to use for screening instead.  Five commercially available inhibitors: 
galantamine, edrophonium, propidium, physostigmine, and BW284c51 were studied in 
order to benchmark the inhibitory KD values determined with BSI.  Next six novel 
inhibitors prepared by the Heindel Lab were studied, and the BSI results were compared 
to IC50 values determined via Ellman’s assay.
40
  Comparison of both techniques’ results 
gave valuable insight into the inhibition mechanisms.  This is especially useful for 
screening for potential anti-Alzheimer’s disease agents that have affinity for the allosteric 
site of the enzyme. 
 Chapter 3 discusses experiments designed to test our hypothesis that BSI could 
distinguish between a complementary DNA duplex and ones containing different single 
nucleotide polymorphisms (SNPs).  This work was expanded from initial experiments 
with 30-base pair oligonucleotides and two adjacent mismatched SNPs.  Here, 20-base 
pair oligomers were used to be more consistent with other techniques used to study SNPs, 
and six duplexes were studied with a constant probe strand: a perfect complement, a 
nonbinding nonsense strand, and two each of a deletion and mismatch SNP at different 
locations within the sequence (centrally-located, or four base pairs from the 3’ end).    
Melting transition temperatures obtained with CD were used to benchmark the BSI 
results.  In addition to basing results on the KD values determined and how they 
compared with the melting temperatures obtained via CD, we also noted interesting 
observations concerning the magnitude of the signal, namely that the complementary 
duplex produced a much higher phase shift compared to the SNP-containing duplexes.  
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 The next project (Chapter 4) examined a series of small organic molecules acting 
as ion-recognition systems, or ionophores, in nonaqueous solvent (acetonitrile, MeCN).  
The goal was to observe their interactions via BSI to gain insight into FreeSRF and the 
source of the BSI signal, particularly from the effects of solvation in nonaqueous media, 
and in systems that do not undergo a significant conformational change typical in many 
biochemical systems.  Systems studied include four potassium-selective ionophores, 18-
crown-6, potassium ionophore I (also known as Valinomycin), potassium ionophore II, 
and potassium ionophore III.  Ionophore II and III’s motion as each ‘captures’ a 
potassium ion mimics that of some larger, biomolecular recognition systems; as a result, 
both this conformational change and any solvation changes within the system were 
expected to have an effect on the BSI signal.   
 18-Crown-6 binding to potassium produced a smaller signal compared to the 
other ionophores.  BSI results of potassium binding with 18C6, ionophore I, and 
ionophore II yielded binding curves in the negative direction.  Potassium Ionophore III is 
structurally similar to the ionophore II, with one notable exception being a dodecyl chain 
in the middle of the linker between the two 15-crown-5 ends.  This hydrocarbon tail has a 
significant impact on the signal and resulted in a positive saturation curve after an initial 
negative phase shift.  
 Finally, other information that can be determined with BSI experiments is 
discussed.  The stoichiometry of a binding system can be determined even at those 
greater than 1:1, provided a single rise-to-max curve is generated.  Decomplexation of the 
valinomycin-potassium complex upon addition of water is observed.  Future experiments 
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are also proposed, including studies involving solvation effects, hydrogen-bonding 
systems, and metal ion sensing. 
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Chapter 2  
BSI as an ultrasensitive method for unperturbed detection of 
Acetylcholinesterase-Inhibitor interactions 
2.1. Introduction 
2.1.1. Acetylcholinesterase function and structure 
Acetylcholinesterase (AChE) is a serine hydrolase enzyme that plays a vital role 
in neurotransmission, outlined in Figure 2.1.  It is found in synapses of neurons and 
muscle cells (or other neurons), also known as a neuromuscular junction, and has one of 
the fastest reaction rates of animal enzymes.  Its substrate is the neurotransmitter 
acetylcholine (ACh), which is hydrolyzed to acetate and choline at the active site of 
AChE to terminate signal transmission in both the peripheral and central nervous system.  
The hydrolyzed choline is then resynthesized to acetylcholine by choline 
acetyltransferase (ChAT) to continue signaling.   ACh also serves as a neuromodulator 
within the brain to affect other functions and processes, including REM sleep.    
 
Figure 2.1. Acetylcholine’s cycle as a neurotransmitter. 
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AChE’s existence and function was first proposed over 100 years ago by Sir 
Henry Dale,
1
 but its structure wasn’t confirmed until 1991, when a form from torpedo ray 
fish was crystallized.
2
  Electric fish like the torpedo provided a good source to study the 
enzyme thanks to high concentrations in the massive amounts of nerve-like structures in 
their electricity-generating organs. 
The active site of AChE is located near the bottom of a 20 Å deep gorge, which 
features hydrophobic walls lined with 14 aromatic residues, and a catalytic triad of serine, 
histidine, and glutamate at the active site.  This gorge reaches almost halfway through the 
enzyme.  A second potential binding site, known as the peripheral anion site (PAS), is 
located at the top of the active site gorge.  It consists of five residues: three tyrosine, one 
aspartic acid, and one tryptophan. Ten other acidic residues located in the surrounding 
area at the top of the gorge account for the overall negative charge of the region.  These 
encompass a variety of modes for interacting with a ligand or inhibitor, including 
aromatic stacking and hydrogen bonds.
3
 
AChE is an important therapeutic target for a variety of reasons, including disease 
prevention and combating chemical warfare.  Toxic sulfur agents or organophosphates 
act as potent inhibitors of the active site and disrupt neurotransmission, causing 
inflammation and muscle over-stimulation due to the inhibited AChE’s inability to break 
down ACh, which results in ACh accumulation at receptors.  In neurodegenerative 
diseases such as Alzheimer’s disease (AD), reduced ChAT activity and cholinergic 
neurotransmission are major factors believed to affect cognitive impairment. 
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Figure 2.2. Diagram of AChE, indicating the active site in the gorge and the peripheral 
site near the top of the gorge.
4
 
 
2.1.2. The Cholinergic hypothesis of Alzheimer’s disease 
 Alzheimer’s disease is a progressive neurodegenerative disease 
characterized by cognitive impairment and memory loss.  It is the most common form of 
dementia in elderly people, affecting nearly 50 million people worldwide.  The 
cholinergic hypothesis of the disease was first developed in the 1970’s when the role of 
ACh in memory was being studied and decreased levels of ACh production in patients’ 
brains were first observed.
5
  It proposed that two of the main pathological markers of the 
disease, buildup of intracellular tau protein tangles and extracellular β-amyloid plaques, 
are a result of deficiencies in cholinergic neurotransmission.  Therefore the progressive 
nature of the disease is due to the loss of neurons that use ACh as the main 
neurotransmitter in certain parts of the brain (basal forebrain) and lowered ACh 
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transmission in other parts (hippocampus and cerebral cortex); in order to alleviate 
symptoms, it would be necessary to restore ACh to higher levels seen in healthy brains.     
Beta amyloid (Aβ) fibrils in extracellular regions are the precurors to the plaques 
observed in the brains of Alzheimer’s patients.  They are formed when the amyloid 
precursor protein (APP) is not cleaved correctly.  Their formation as a cause of the 
disease, rather than a symptom of lowered ACh as described in the cholinergic 
hypothesis, was initially described as part of an “amyloid hypothesis” of AD.  While the 
formation of plaques serving as a symptom versus a cause of the disease is still debated,  
the PAS of AChE has been shown to play a role in Aβ deposition.3,6  Increased 
aggregation of the fibrils accelerates the formation of the plaques, and the PAS mediates 
and accelerates fibril aggregation by inducing beta-sheet conformational changes in the 
amyloids.  Thus, the first AChE inhibitors (AChEIs) were designed to combat the 
symptoms of AD and restore cognitive functions by increasing ACh levels in the brain, 
i.e. inhibitors would prevent AChE from hydrolyzing ACh, while later AChEIs have been 
designed to also target the PAS in an attempt to block the aggregation of Aβ fibrils.7,8 
2.1.3. Acetylcholinesterase Inhibitors  
Several inhibitors of AChE exist on the market, encompassing a wide variety of 
inhibition mechanisms, whose functions and binding targets determine their purposes.  
Tacrine was the first inhibitor approved for treatment of AD in 1993, though it only ever 
produced modest results in restoring cognitive ability, caused potentially serious side 
effects including seizures and cardiovascular issues, and was discontinued in the US in 
2013.  It and donepezil, the second AChEI on the market, both functioned as mixed 
inhibitors of AChE, with slight affinity for both the active and peripheral sites of the 
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enzyme (donepezil was more selective and potent).
7
  Since then, several other AChEIs 
were introduced to the market to combat the symptoms of AD.  Edrophonium is a 
reversible competitive inhibitor that was used in the past to test for myasthenia gravis, a 
neuromuscular disease.  The carbamates, pseudo-irreversible competitive inhibitors, 
including Physostigmine and derivatives Neostigmine and Rivastigmine, are cleaved and 
covalently modify the enzyme at the active site serine, but are slower compared to other 
inhibitors.
9
  Galantamine is another mixed inhibitor first industrially isolated as natural 
product from snowdrop flowers in the 1950s.  Propidium, a noncompetitive inhibitor with 
affinity solely for the PAS, is also used to treat Alzheimer’s disease.  The discovery of 
the role of the PAS in Aβ aggregation made noncompetitive inhibitors such as propidium 
desirable targets. 
Structure-activity relationship (SAR) studies have determined appropriate linkers 
and molecule lengths for mixed inhibitors, such as BW284c51, to target both the active 
and peripheral site.
10
  In the case of potential anti-Alzheimer’s drugs, targeting of the 
PAS is preferred in order to prevent the deposition of the Aβ fibrils that lead to plaque 
formation.  Thus, any drugs designed for these purposes tend to be noncompetitive 
inhibitors, such as propidium, or mixed inhibitors to target both the cholinergic 
hypothesis and amyloid hypothesis causes of the disease. 
Despite the availability of these AChE inhibitors, there exists a need for improved 
treatment options for a variety of reasons.  Typically patients taking donepezil, 
galantamine, or rivastigmine see improvement in cognitive abilities only temporarily, up 
to a year, before worsening again.
11
  Additionally, many of these inhibitors were designed 
to target the active site, with the role of the PAS in disease progression being a more 
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recent discovery, so better targeting of the PAS site would be desirable, either as solely 
noncompetitive inhibitors, or dual-binding inhibitors with high affinity for both sites.  
Finally, in addition to the need for new AChE inhibitors, a rapid, straightforward method 
to screen potential inhibitors would provide a great advantage to AChEI research, as well.   
2.1.4. Methods to determine inhibition activity 
One common method for determining the effectiveness of a potential inhibitor of 
AChE is the use of Ellman’s Assay to determine IC50 values, or the half maximal 
inhibitory concentration, for each potential inhibitor.  The IC50 values define the 
concentration of the inhibitor required to inhibit 50% of the target’s normal activity.  
Ellman’s Assay is a colorimetric assay developed in 1961 to measure inhibition of AChE 
by quantifying the absorbance of the hydrolyzed product of Ellman’s reagent, 
dithionitrobenzoic acid (DTNB).
12
  The procedure, shown in Scheme 2.1, begins with 
AChE, the potential inhibitor, and acetothiocholine (ATCh), a derivative of the natural 
ACh substrate.  Upon interaction with the enzyme, ATCh is hydrolyzed to its thiol form, 
which can then attack the S-S bond of DTNB.  Cleavage of this bridging sulfur bond 
yields 2-nitro-5-thiobenzoate ion, which, in basic media, ionizes again to the dianion 
(TNB
2-
) and results in a yellow solution.  The reaction is stoichiometric, and the 
absorbance change based on the colored dianion product is measured.   
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Scheme 2.1. Ellman’s Assay. 
 
This assay is an indirect measurement of substrate inhibition through 
determination of the absorbance of the cleaved Ellman’s reagent at 412 nm.  The 
concentration of the reagent is then determined via Beer’s Law, which is related 
stoichiometrically to the amount of substrate hydrolyzed by the enzyme.  Thus, a stronger 
inhibitor would result in a lower concentration of colored reagent, as less ATCh would 
have been initially hydrolyzed by AChE.  This procedure is less effective for screening 
inhibitors of the PAS, and is prone to false positives in the presence of strong 
nucleophiles, such as oximes, which have been used as antidotes to reactivate AChE that 
has been inhibited by organophosphate poisoning.  In these instances, the nucleophilic 
oxime could hydrolyze ATCh, instead of AChE hydrolyzing it, and result in an 
erroneously high concentration of the cleaved and colored TNB
2-
, making a potential 
inhibitor seem less effective than it actually is.  Sakurada and coworkers discovered this 
effect in 2006, decades after Ellman’s Assay had been developed, when they measured 
reactivation of AChE with increasing amounts of pralidoxime iodide (2-PAM) via this 
assay, and noticed activity levels beyond the negative controls.  This study stressed the 
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need for careful analyses in activity studies, and a major potential drawback of using 
indirect measurements or derivatives of natural substrates.
13
 
To circumvent these false positives, other methods of AChE inhibitor 
measurements have been developed. Ideally, experiments would either use the natural 
ACh as a substrate, or require no substrate at all.  Many are fluorescent or 
chemiluminescent assays, including dioxetane-disulfide derivatives of Ellman’s 
Reagent,
14
 cascading fluorescence ‘turn-on’ reactions,15 or larger molecular probes 
including fullerene derivatives.
16
  These typically require time-consuming and laborious 
procedures, but have produced some of the lowest limits of detection available, down to 
0.1 fM in the case of some dioxetane chemiluminescent probes.
17
 
2.1.5. BSI as a desirable platform for enzyme inhibitor screening 
As discussed previously in Chapter 1, the presence of fluorophores can perturb 
binding, so for a true measurement of native binding strength, label-free detection 
methods at relevant physiological conditions are preferred.  BSI appears to be a desirable 
platform for these types of inhibition studies, as experiments are performed label-free at 
low concentrations, and in free solution.  The straightforward procedure and sample 
preparation allow the screening of a variety of different inhibitors.  Additionally, for 
enzymes such as AChE which can cost hundreds or even thousands of dollars per mg, 
BSI’s small sample size, with a probe volume of less than 400 pL for the original chips 
used in this study (7.52 nL in the present chips with wider channels), offers an advantage 
as well.  Another advantage is that BSI measurements are a direct measurement of the 
inhibitor interacting with the enzyme with no substrate (ACh or ATCh) present.  Thus, 
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experiments were designed to measure inhibition KD values (or Ki’s) of potential 
inhibitors of AChE via BSI.   
The goal of this study was to compare and benchmark Ki’s determined with BSI 
to 1) previously determined Ki values of known AChE inhibitors determined by a variety 
of fluorescent assays, and 2) previously determined IC50 values of novel AChE inhibitors 
via Ellman’s assay.  With these results we sought to show that inhibitor affinities 
determined with BSI correlated well with those determined by Ellman’s assay and other 
methods, showing that BSI would be a more preferred approach for inhibition studies due 
to its many advantages, including being performed label-free, in free solution, substrate 
free, and at physiological conditions and low concentrations without laborious 
procedures.  Finally, BSI experiments would allow for potential new anti-Alzheimer’s 
agents to be discovered and screened more rapidly.   
2.2. Materials and Methods 
2.2.1. Instrument and chip channel preparation 
The instrument (detector/computer, laser, and temperature-controller) was 
equilibrated at least one hour prior to experiments.  The stage containing the microfluidic 
chip was held at a constant 25 °C. 
The microfluidic chip used for these experiments contained three channels that 
were 90 μm in diameter. For each experiment, the channels were silanized with 3-
mercaptopropyltriethoxysilane (MEPTES) to prevent nonspecific interactions with the 
walls (Figure 2.3).  This procedure involved an initial hour soak in concentrated H2SO4 in 
order to fully clean any remaining materials or residues in the channel, followed by a half 
hour soak with a 10% KOH/MeOH solution, refilled every eight to ten minutes to prevent 
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drying and clogging.  This was followed by a rinse with water and methanol.  Next, an 
hour-long soak of the silanizing agent, MEPTES (2% in toluene) was performed, with 
refills every 15 min to prevent drying. This was again followed by toluene, methanol, and 
water rinses.  After all channels within the chip were used, chips were rinsed with water, 
sonicated for 30-60 min, and resilanized.  Clogs could be cleared by rinses with 
concentrated HNO3 (soaks with nitric acid lasted no more than 5 min), and additional 
sonication and rinsing with water.  The narrower channels were more prone to clogs, 
typically due to precipitation from the nearly-saturated KOH/MeOH solution, than the 
newer, 210 μm diameter channels used in later projects. 
 
Figure 2.3. Silanization of channel walls with MEPTES to avoid nonspecific interactions 
of hydrophilic analytes with the wall. 
 
2.2.2. Preparation of samples 
The Heindel research group has produced a variety of potential inhibitors of 
AChE through various SAR studies.
18
  While many of these have applications for anti-
inflammatory purposes, depending on their preferred targeted site and inhibition 
mechanism, some were also considered suitable for potential anti-Alzheimer’s agents.  
Six of these novel inhibitors were the inhibitors selected for the present study.  
Additionally, five known and commercially-available inhibitors were used in order to 
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benchmark the BSI experiments.  Table 2.1 lists information for the known inhibitors, 
and Table 2.2 lists information for the novel inhibitors.  The novel inhibitors were 
prepared as previously described.
18
 The phosphate-buffered saline (PBS), and any 
cosolvent, was filtered with 0.2 μm membrane filters before use.  AChE, from Sigma-
Aldrich, was dialyzed against PBS (3 x 300 mL) using regenerated cellulose dialysis 
tubing (weight cutoff 3500 Da), and portions were frozen to be stored for use as needed.     
Cosolvents (10% MeOH, or 5% DMSO or 2(2-ethoxyethoxy)ethanol) were used 
to increase the solubility of the novel inhibitors due to their high lipophilicity.  Initially 
concerns over using MeOH as a cosolvent due to its higher volatility influenced us to 
switch to the other cosolvents at lower amounts, but these experiments showed no 
significant improvements to errors in the experiments.  Therefore MeOH as a cosolvent 
in PBS was used and collection times were shortened by 15-20 seconds to account for the 
faster evaporation time, which causes greater amounts of error and drift in the BSI signal.  
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Table 2.1. Known inhibitors used for BSI experiments in PBS. 
Ligand Structure Conc. Range (µM) [AChE] (µM) 
Edrophonium 
 
0-8.0 1.4 
Physostigmine 
 
0-2.5 0.36 
Galantamine 
 
0-5.0 0.18 
Propidium 
 
0-10.0 0.72 
BW284c51 
 
0-100 nM 72 nM 
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Table 2.2. Novel inhibitors used for BSI experiments in PBS:MeOH (9:1) 
Ligand Structure Conc. Range (µM) [AChE] (µM) 
 
1 
  
0-1.0 0.0072 
 
2 
  
0-6.0 0.36 
 
3 
  
0-12.0 1.4 
4 
 
0-3.0 6.9 
5 
 
0-6.0 1.4 
6 
 
0-3.0 2.5 
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To ensure the concentration of AChE was not too high to cause aggregation, 
[AChE] was held constant below 6.9 μM while increasing concentrations of the inhibitors 
were added to each sample.  The concentrations of the inhibitors used were based on IC50 
values determined with Ellman’s method (for the novel inhibitors) or with previously 
published Ki’s (for the known inhibitors).
19–26
  Samples were allowed to equilibrate at 4 
°C for at least 3 hours before use.  Enzyme and ligand blanks were prepared to account 
for any concentration-dependent signal changes above the noise that would need to be 
subtracted out, however, the ligand blanks did not result in a readable signal above the 
noise level of the instrument.  Samples were kept covered and over ice during 
experiments to ensure stability. 
2.2.3. Data collection  
Water followed by PBS buffer (or PBS:MeOH mixed solvent) were first pipetted 
into the channel to ensure a stable and repeatable signal.  Next, blanks containing only 
inhibitor were run in order to subtract out any concentration-dependent signals above the 
noise level, however, the ligands on their own did not produce a readable signal at the 
concentrations used.  The sample containing only buffer and AChE was the initial ‘zero 
point,’ which was subtracted from each subsequent point (samples containing enzyme 
and inhibitor) to normalize the binding curve to a constant baseline.  After each injection, 
data was collected for approximately 45-60 seconds, to avoid any initial baseline 
disruption immediately following injection and ensure equilibration in the channel.  
Shorter collection times were used for samples containing a cosolvent of 10% MeOH to 
avoid evaporation of the sample solution in the channel, which results in spurious and 
drifting signals. 
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2.2.4. Data Analysis 
Binding curves were plotted as a function of phase shift versus inhibitor 
concentration in Excel, and Ki values were calculated using the one-site binding 
hyperbola equation in GraphPad Prism and Excel.  Each point in the curve was based on 
the average signal of each sample, with typically 5-10 trials collected over two or three 
days.  Error bars are based on the standard deviation of each concentration point, and 
error in the Ki was propagated from each point.  
2.3. Results & Discussion 
2.3.1. Benchmarking of BSI results to previous results of known inhibitors 
The known inhibitors in this study encompassed a wide range of affinities and 
various types of inhibition mechanisms.  Edrophonium is a competitive inhibitor, 
propidium is a noncompetitive inhibitor, galantamine and BW284c51 are mixed 
inhibitors, and physostigmine is a pseudo-irreversible carbamate (mixed) inhibitor.  
These inhibitors each interact differently with AChE, but each resulted in a single rise-to-
max binding curve increasing in the positive direction at varying magnitudes.  Ki values 
determined using BSI correlated well with previously determined Ki’s determined by a 
variety of techniques, summarized in Table 2.3.  Each individual binding curve is 
represented in Figures 2.4—2.8, and each point on the curves are the result of five or 
more trials over two or more days. 
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Figure 2.4. BSI binding curve of AChE (1.4 μM) with edrophonium in PBS. 
 
 
 
Figure 2.5. BSI binding curve of AChE (0.72 μM) with propidium in PBS. 
 
 
 
Figure 2.6. BSI binding curve of AChE (0.18 μM) and galantamine in PBS. 
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 Figure 2.7. BSI binding curve of AChE (72 nM) and BW284c51 in PBS. 
 
 
 
 Figure 2.8. BSI binding curve of AChE (0.36 μM) and physostigmine in PBS. 
 
Table 2.3. Comparison of BSI KD/Ki values to literature KD values. 
Inhibitor BSI KD (µM) Literature KD (µM) Ref. 
Edrophonium 1.27 + 0.4 1.5-3.8 
19,20
 
Physostigmine 0.020 + 0.009 0.013-0.11 
21,22
 
Galantamine 1.23 + 0.5 0.20-0.61 
23
 
Propidium 0.64 + 0.09 0.63-1.5 
19,24
 
BW284c51 8.4 + 2.0 nM 3.2-8.0 nM 
26,27
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All inhibitors produced a binding curve in the positive direction at similar 
magnitude, with a maximum signal, or RI shift, between 0.03-0.08 radians.  The signal is 
believed to be a result of conformation, solvation, and polarizability changes as the 
inhibitor binds to the enzyme. 
2.3.2. Comparison of BSI results to Ellman’s assay results of novel inhibitors 
As BSI experiments using novel AChE inhibitors continued, expected similar 
results to the known inhibitors were expected.  However, comparison of the BSI Ki 
values of the novel inhibitors to the IC50 values determined via Ellman’s assay showed 
quite different results, as summarized in Table 2.4.  Figures 2.9-2.12 show the BSI 
binding curves for each ligand.  
 
Figure 2.9. BSI binding curve of AChE (7.2 nM) and Ligand 1 in 9:1 PBS:MeOH. 
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Figure 2.10. BSI binding curve of AChE (0.36 μM) and Ligand 2 in 9:1 PBS:MeOH. 
 
 
Figure 2.11. BSI binding curve of AChE (1.4 μM) and Ligand 3 in 9:1 PBS:MeOH. 
 
 
Figure 2.12. BSI binding curve of AChE (1.4 μM) and Ligand 5 in 9:1 PBS:MeOH. 
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Table 2.4. BSI Ki/KD values compared to Ellman IC50 values. 
Ligand BSI KD (µM) Ellman IC50 (µM)
18
 
1 0.11 + 0.05 0.51 + 0.02 
2 0.21 + 0.05 1.36 + 0.1 
3 2.18 + 1.1 2.69 + 0.1 
4 dual-binding 6.34 + 0.5 
5 0.12 + 0.04 2.29 + 0.9 
6 dual-binding 13.9 + 0.3 
 
Only one inhibitor in this study had a Ki that matched its IC50.  While differences 
between IC50 and Ki determinations have been reported, these were typically due to 
experimental conditions when determining IC50, such as the concentration of substrate or 
the temperature or pH of the assay,
 
or for more complex inhibition mechanisms or 
enzymes with two substrates. In such instances, differences of up to two orders of 
magnitude or more have been observed.
28
  On the other hand, Ki values are intrinsic 
properties independent of assay conditions.  The differences between these novel 
inhibitors’ IC50 and Ki values were initially puzzling, but can be explained with the 
Cheng-Prusoff relationship (Scheme 2.2), which describes the differences between the 
systems being probed with both techniques (BSI and Ellman test).
29
  It describes that, for 
noncompetitive or mixed inhibition pathways and a high concentration of substrate (like 
in conditions for the Ellman assay), the IC50 is equal to the inhibitor’s affinity for the 
enzyme-substrate complex, which could be denoted as a Kies.  With no substrate present, 
the affinity of the inhibitor is for the enzyme only, or a Kie. 
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Scheme 2.2.  The Cheng-Prusoff relationship describes the relationship between the BSI 
KD (or in this case, Ki) and IC50 determined via Ellman’s Assay. 
 
The Cheng-Prusoff relationship highlights that the equilibria being measured with 
BSI and with Ellman’s assay are not the same due to the presence or absence of substrate 
(acetylcholine or a derivative), thus, the relationship between IC50 and Ki can vary.  In 
BSI experiments, with no substrate present, the dissociation constant being measured is 
between the enzyme and inhibitor only, and the active site is available.  Conversely, with 
a high concentration of substrate (as in Ellman’s assay), the equilibrium exists between 
the inhibitor and the enzyme-substrate complex, and the active site is occupied by the 
substrate.  Whether the inhibitor behaves differently between the enzyme and the 
enzyme-substrate complex depends on the inhibition mechanism; since BSI experiments 
measure the affinity of the enzyme alone (no substrate present) and experiments using 
Ellman’s assay measure the affinity of the enzyme-substrate complex, comparisons of 
these values yields insight into the inhibitors’ inhibition mechanisms.   
Upon reexamination of the results, it was concluded that, in instances where the 
Ki is equal to the IC50 (within experimental error), as is the case with ligand 3, the 
inhibitor’s affinity for the enzyme is the same regardless of the presence of substrate (Kie 
= Kies = Ki); this means the ligand has affinity for the peripheral site alone, and acts as a 
noncompetitive inhibitor.  In cases where the Ki is significantly lower than the IC50, 
namely ligands 1,2, and 5, it indicates that these ligands have affinity for the active site in 
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addition to any peripheral site affinity, and act either as competitive or mixed inhibitors, 
with affinity for both sites.  In the BSI system with no substrate present, they are able to 
bind to the active site, and have a greater affinity overall to the enzyme, resulting in a 
lower Ki value.  These differences between IC50 and Ki can also be described 
mathematically from the Michaelis-Menton equation (1) based on the type of inhibition. 
   
       
      
      (1) 
In the Michaelis-Menton equation, V0 is the velocity of the enzyme-substrate 
interactions, Vmax is the maximum velocity, [S] is the concentration of substrate, and Km 
is the Michaelis constant. A competitive inhibitor has affinity solely for the active site, 
i.e. the enzyme and not the enzyme-substrate complex.  Competitive inhibition alters the 
kinetics of the enzyme-substrate complex by increasing the apparent Km of the system, 
which decreases the velocity, as shown in Equation 2. 
   
       
       
   
  
     
     (2) 
Here, VI is the velocity with inhibitor present at a concentration [I], and Ki is the 
inhibitory dissociation constant. When [I] = IC50, the velocity is half of V0, and Cheng 
and Prusoff demonstrated how the above equation can be rearranged to Equation 3 to 
show the relationship between the IC50 and Ki of a given enzyme-competitive inhibitor 
system.
29
 
            
   
  
      (3) 
For noncompetitive inhibition, Vmax is reduced but Km does not change, so the 
Michaelis-Menton equation takes into account the apparent Vmax as shown in Equation 4.  
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The inhibitor has the same affinity for both the enzyme itself and the enzyme-substrate 
complex (Kie = Kies = Ki) 
   
       
     
    
  
        
    
  
 
    (4) 
When [I] = IC50, V0 = 2VI, and the equation can be simplified to IC50 = Ki.
29
   
The results from comparing BSI Ki values to the IC50 values make it possible to 
distinguish between a true noncompetitive inhibitor and competitive or mixed inhibitors, 
but not necessarily between a competitive inhibitor and a mixed inhibitor.  The two 
remaining ligands featured different results that may also yield some insight into their 
affinity for AChE. 
 
Figure 2.13. BSI binding curve of AChE (6.9 μM) and Ligand 4 in 9:1 PBS:MeOH; the 
inset shows the two separate binding events, and the larger plot shows the fit to an 
isolated second binding event. 
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Figure 2.14. BSI binding curve of AChE (2.5 μM) and Ligand 6 in 9:1 PBS:MeOH, 
featuring two separate rise-to-max events. 
 
In the case of the remaining two ligands (4 and 6), two separate rise-to-max 
binding curves were observed upon increasing inhibitor concentration, where the signal 
increased up to a certain point then reversed back near the initial starting phase baseline, 
before continuing to increase as what appeared to be a second binding event.  These 
binding curves are shown in Figures 2.13 and 2.14.  It was difficult to calculate a Ki for 
these ligands (For Ligand 4, zeroing the second binding curve and treating it as an 
isolated event yields a Ki of 0.97 + 0.57 μM), but these results give interesting insights 
into the inhibitors’ behavior nonetheless.  It seems these inhibitors can also act as a type 
of mixed inhibitor, with affinity for both the active and peripheral site, and subsequent 
binding induces changes to the system that register as a different change in signal for the 
BSI.  In the case of AChE, this could be a result of solvent molecules being expelled 
from the active site gorge and a subsequent conformational change to allow for the 
inhibitors to access both sites.
30–32
 
BSI provides valuable insight into inhibition mechanisms when directly compared 
with results obtained via the Ellman method.  The Cheng-Prusoff equation highlights the 
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relationship between the enzyme and the enzyme-substrate complex with a given 
inhibitor, as well as the differences in the equilibria being measured by each technique.  
Specifically, BSI is able to distinguish between mixed or competitive inhibition 
mechanisms and true noncompetitive binding.  This is vitally important for potential 
Alzehimer’s disease inhibitor research, as AChE inhibitors designed as anti-Alzheimer’s 
agents would preferentially target the PAS in a noncompetitive manner.  Competitive 
inhibitors, such as edrophonium, which selectively target the active site, showed no signs 
of suppressing the enzyme-induced Aβ aggregation.  Most mixed inhibitors provide only 
moderate results at best, typically less than 30% suppression.
10,33
  On the other hand, 
propidium, one of the true PAS-specific inhibitors, can suppress aggregation by up to 
82%.
33
  In addition to identifying inhibitors capable of targeting the PAS in order to 
prevent Aβ aggregation, BSI would also make it easier to screen subsequent inhibitors to 
act as potent mixed inhibitors that also target the active site to restore cholinergic activity.      
2.3.3. Determination of the limit of detection 
We next sought to determine the limit of detection when using BSI to detect 
inhibition of AChE.  In order to measure this, we used the known inhibitor BW284c51, 
which had the highest affinity (lowest Ki) for AChE of the inhibitors used in this study.  
At the lowest limit with a readable signal, concentrations of 100 pM of enzyme could be 
detected.  When taking the probe volume of the instrument into account, which for the 
channels used was about 360 pL, this equates to an astonishing limit of 23,000 molecules.  
This limit meets or exceeds a variety of techniques’ limits of detection, all of which 
require complex probes or fluorophores,
15,17,34,35
  while still being a result of a label-free 
and free-solution technique that avoids these costly procedures.   
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2.4. Conclusions 
The results presented in this chapter demonstrate the many advantages BSI offers 
for analyzing enzyme-inhibitor interactions, including 1) low-volume and low-
concentration samples, yielding more cost-effective experiments with less waste, 2) free-
solution and label-free experiments that provide a LOD comparable to more complex 
fluorescent, colorimetric, and electrochemical techniques, 3) the ability to directly 
measure the Ki of enzyme inhibition systems and thus avoid false positive signals, and 4) 
the ability to gain insight into the types of inhibition mechanism by which an inhibitor 
operates, which is accomplished by comparing the BSI results to data obtained using 
systems that examine the enzyme-substrate complex, such as Ellman’s assay.  The 
technique is not without its drawbacks, however.  When designing experiments with 
novel inhibitors or receptors, where less information on the characterization and 
interactions of the system is available, care must be taken to avoid too high 
concentrations, as this could cause either aggregation of the substances, or result in 
product complex concentrations where the mass-dependent RI changes overshadow the 
signal changes from the actual binding event.  Additionally, cosolvents may be necessary 
for ligand solubility, but greater amounts of more volatile solvents increase the likelihood 
of solution evaporation in the channel.  Solvent selection is also dependent on its index of 
refraction, which must not be too close to that of the microfluidic chip to ensure quality 
high-contrast fringes are generated. 
The main advantage highlighted in this specific study is the ability to gain insight 
into an inhibitor’s mechanism of action by comparing the BSI results to other techniques’ 
results.  This is especially important for potential anti-Alzheimer’s agents, where 
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noncompetitive inhibitors are necessary to be most effective.  BSI’s small sample size 
can continue to aid in this field of research, where, for instance, it may be possible to 
further analyze inhibitor affinity for each site individually by using modified versions of 
the enzyme to ‘shut down’ one site, and specifically measure binding to the other.  In a 
similar vein, studies with Butyrylcholinesterase (BChE), a similar enzyme but which 
lacks the peripheral site, could be performed with near-identical procedures to test 
inhibitor affinity for the active site separate from the PAS.  The small sample sizes would 
allow for cost-effective amounts of both native and modified forms of the enzymes to be 
prepared.   
Finally the procedures used for this study could also be applied to other enzyme 
inhibition systems, including orphan receptors.  These receptors are usually structurally 
similar to known receptors, however they have no known endogenous ligand, such as 
acetylcholine to AChE.  Thus, their natural function remains unknown.  For example, G-
protein coupled receptors (GPCRs) are a large and diverse class of proteins that 
participate in a wide array of natural functions, including many types of signal 
transductions.  They are also some of the most successful targets of pharmaceuticals, but 
over 100 human GPCRs still have no identified natural ligand.
36
  Combining 
computational library screening with screening experiments via BSI would allow for an 
efficient method to identify potential receptors and targets, and from there, potential 
medicinal uses.  Similar screening studies could be performed with known receptors, as 
well, for expanded SAR studies of potential ligands or inhibitors. 
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 Chapter 3   
Detection of various single nucleotide polymorphisms in short dsDNA sequences 
 
3.1. Introduction to single nucleotide polymorphisms (SNPs) 
 The human genome is comprised of approximately 3 billion DNA bases in the 
chromosomes, Adenine (A), Thymine (T), Cytosine (C), and Guanine (G).  Typical base-
pair hydrogen bonding, the Watson-Crick base pairs that form the helical DNA duplex, is 
shown in Figure 3.1.  The study and characterization of nucleic acid hybridization, or 
duplex formation, (both DNA and RNA) is an important area of biochemical research 
even after the sequencing of the entire human genome.  The sequence of a series of 
nucleotides determines function in a gene, so if an alteration of an expected sequence 
occurs, the desired function can be significantly altered.  Single nucleotide 
polymorphisms (SNPs) in DNA, where a given nucleotide base is missing, replaced by a 
different base, or added to the sequence, account for the majority of genetic sequence 
variation in humans and other species.  They occur at a rate of approximately 0.1% in the 
human genome, which accounts for less than 3 million bases out of the 3 billion that 
comprise the entire genome.
1
  Most are harmless, can be used to determine ancestry, or 
explain differences in appearances, such as hair or eye colors. 
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Figure 3.1.  Watson-Crick base pairing of adenine and thymine (left), and guanine and 
cytosine (right). 
 
3.1.1. Stabilities of SNPs in a DNA sequence 
 Different SNP mismatched pairings have different destabilizing effects.  Their 
stabilities are affected by a variety of factors, including the number of hydrogen bonds 
between two bases, backbone shape, and π-stacking effects; thus, the stability of a 
particular base pair is also affected by their flanking bases (nearest neighbor, NN, 
effects).  These effects were studied computationally by SantaLucia and coworkers.
2
   
 
Figure 3.2. Order of thermodynamic stabilities of all possible base pairs determined by 
NN calculations.
2
 
 
 The Watson-Crick GC base pair is stronger than AT due to the additional 
hydrogen bond, and similarly, bases flanked by GC pairs are slightly more stabilized 
compared to the same pair flanked by AT pairs.  Helical constraints make purine-purine 
base pairings unfavorable due to being too large, while pyrimidine-pyrimidine base 
pairings are too small. 
 With an insertion or deletion of one base, a single base bulge is formed in the 
duplex, which typically disrupt the helical axis by looping out and away from the axis.
3,4
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In folded RNA, bulges serve as highly recognizable and selective features for protein 
binding, but in helical DNA they are very destabilizing.
4,5
  Nearest neighbor effects play 
a role in bulged duplex stability as well, with an effect known as positional degeneracy 
that makes bulged bases more stable if they are flanked by the same base.
5,6
   
3.1.2. The role of SNPs in genetic diseases 
The ClinVar database is a large compilation of SNPs that have been found and 
associated with a particular disease or condition.  Certain SNPs in the regulatory or 
coding region of genes (exons) increase an individual’s susceptibility to certain diseases 
or health conditions by introducing premature stop codons, or coding for alternative 
amino acids to disrupt a protein’s function.  Examples include hypertension, osteoporosis, 
Celiac’s, cystic fibrosis, and certain cancers.7,8  This is in contrast to diseases or 
conditions caused by microdeletions, in which small portions of a gene are missing (no 
greater than 5 million base pairs).   
The presence or absence of a SNP does not guarantee an individual will be 
afflicted with a given condition or disease, and sometimes a combination of several SNPs 
on different genes must all be present to cause the disease.  For example, several 
insertions have been identified on chromosome 17 that are associated with Hereditary 
Breast and Ovarian Cancer (HBOC), including two A insertions.  These polymorphisms 
have been found to predispose individuals to early onset breast, ovarian, or fallopian tube 
cancers, with a lifetime risk of breast cancer over 50%.
9,10
   
Another example of a disease caused by more than one SNP is X-linked 
myopathy with excessive autophagy (XMEA), a disorder that is marked by weakening 
and degeneration of skeletal muscle tissue.  Six mismatch SNPs were identified on the 
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VMA21 gene on the X chromosome, each contributing to disruptions in RNA splicing 
that ultimately led to decreased V-ATPase activity, which led to increased lysosomal 
pH.
11,12
  Conversely, an example of a disease that is caused by only a single SNP on a 
single gene, known as a Mendelian or single-gene disorder, is Factor V Leiden, which 
causes excessive clotting in the bloodstream.  The most common SNP variant in this 
disease is a mismatch that replaces a G with an A.
13
   
Identifying new SNPs may help pinpoint potential causes or targets of a disease.  
Additionally, understanding particular SNPs or mapping known SNPs in important 
genetic regions may assist in advancing fields of personalized medicines.  A better 
understanding of a SNP’s location would allow for a more thorough understanding of its 
specific role in the disruption of a gene’s desired function, and a better understanding of 
the binding affinities of SNP-containing duplexes could aid in the development of 
methods to restore normal function.  Thus, a simple, straightforward, and rapid approach 
to detecting SNPs in DNA is important for disease detection and diagnostics. 
3.1.3. Common methods to detect SNPs 
Many experiments designed to detect SNPs in short (typically <30 base pairs) 
oligonucleotide sequences use fluorophores tethered to a duplex to measure binding 
interactions,
14
 gold nanoparticles, where a probe strand is functionalized to the surface of 
the NPs, and produces a measurable absorbance change in the visible light region upon 
introduction of a complementary sequence,
15,16
 surface plasmon resonance (SPR), where 
a probe strand interacts with a strand containing a SNP which can then target a probe 
tethered to the surface,
17
 or molecular beacons (MBs).
18–21
  MBs were developed in the 
past 20 years to detect specific oligonucleotide sequences and have been used 
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successfully to separate and score SNPs during PCR.
19
  One drawback of MBs is their 
limited sensitivity due to background signal and inefficient fluorophore quenching.
18
  
Methods to overcome these drawbacks and increase sensitivity have been developed, 
such as using graphene oxides as nanoquenchers,
20
 conjugating new fluorescent dyes,
21
 
and other amplification techniques.
18
  However, generation or conjugation of MBs and 
any additional components can be tedious and costly.  Similarly, syntheses of 
fluorophores and tethering components to a surface can involve laborious procedures.   
Perhaps more importantly, an earlier study using BSI to detect DNA 
hybridization, as discussed previously in section 1.3.2, demonstrated the significant effect 
actions such as fluorophore labeling or tethering an analyte have on the binding affinity 
of the two binding partners, with perturbations causing up to a 50% difference in binding 
affinity.
22
  Obtaining a true measure of affinity at relevant conditions is desired, and BSI 
provides a suitable platform for such measurements in free-solution, and label free.  
3.1.4. Previous BSI hybridization experiments 
Prior experiments probing DNA duplexes and SNPs with BSI demonstrated the 
ability to identify a two base-pair mismatch centrally located in the sequence with this 
technique based on a significant destabilization effect, and a higher dissociation constant 
for the duplex.  Conversely, the same two base-pair mismatch located at the 5’ terminal 
position showed a stabilizing effect (lower dissociation constant).
22
 These experiments 
were performed with 30-base pair oligonucleotides.  We thus sought to determine 
whether BSI would be able to distinguish a single SNP, rather than two adjacent ones, 
based on differences in KD values.  Additionally, would BSI be able to distinguish 
between different types of SNPs?  This previous study probed an A/G mismatch, where 
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the G replaced the complementary T.  We planned to use the same A/G mismatch, but 
also study two sequences containing a T deletion, as well.  Finally, we also sought to 
observe the difference in stabilities when the same SNP is located in different locations in 
the sequence.  Since terminal mismatches have shown to have negligible or even slightly 
stabilizing effects, and centrally-located mismatches have a destabilizing effect, we 
expected a SNP located between the middle and end of the sequence, about a quarter of 
the way from the end, would still destabilize the sequence, but to a lesser degree than a 
centrally located SNP.   
The BSI experiments designed for this expanded SNP research used shorter, 20-
base pair sequences to be more consistent with other techniques.
15–18
  We hypothesized 
that BSI would have the ability to distinguish between a single mismatch or deletion at 
different locations in the sequence, in the middle or nearer to the end, and a perfect 
complement, with each strand interacting with the same actin probe strand.  A non-
binding nonsense strand was used as a negative control to demonstrate the generation of 
negligible binding signal upon mixing and equilibration of the two oligonucleotides, 
highlighting that the signal arises from the DNA hybridization, rather than simply 
increasing concentrations of analytes present.   
Results obtained with BSI were benchmarked with hyperchromicity studies and 
melting temperatures obtained using a CD spectrometer.  Hyperchromicity is a property 
of duplexed DNA that describes the increase in UV absorbance (measured at 260 nm) as 
the duplex is slowly heated and denatured, causing the single strands to separate.  More 
heat is required to denature sequences with a higher affinity, thus higher melting 
transition temperatures (Tm) are indicative of tighter binding in a similar way that lower 
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KD values indicate tighter binding, and so a lower KD value obtained from a BSI 
experiment would correlate with a higher Tm value obtained from the CD.     
The ability of BSI to distinguish between a perfect complement duplex and a 
variety of SNPs label-free and in free solution allows for a true measure of duplex 
affinity without any additional components or perturbations, and would make BSI a 
powerful tool for future research regarding SNP detection and diagnostics.  With a probe 
volume of just 7.52 nL and an oligonucleotide concentration ranging from 25-250 nM, 
BSI uses substantially fewer materials than more common free-solution techniques such 
as isothermal titration calorimetry (ITC) or melting transition studies, which require 
higher volumes and concentrations.  It also requires no PCR amplification.  The small 
sample sizes and straightforward procedure make BSI an ideal candidate for an analytical 
instrument that can be used to detect SNPs in a duplex, or eventually, for diagnostics in 
seeking a particular SNP versus a complement sequence of a target region. 
3.2. Materials and Methods 
3.2.1. Functionalization of chip channels 
The channels in the glass microfluidic chip were silanized to prevent nonspecific 
binding of the oligonucleotides to the channel walls upon introduction of sample.  After a 
one hour sulfuric acid soak to clear the channels, they were rinsed with water and 
methanol, followed by a half hour soak of a 10% solution of KOH in MeOH.  The wells 
of the channels were refilled every eight to ten minutes to prevent drying.  Next, the 
channels were rinsed with water, methanol, and toluene.  They were then filled with a 2% 
solution of 3-mercaptopropyltriethoxysilane (MEPTES, Sigma Aldrich) in toluene for 
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one hour, with refills every fifteen minutes to prevent drying.  Finally, the channels were 
rinsed with toluene, methanol, and water, and the chip secured in the stage. 
3.2.2. Oligonucleotide sample preparation 
Oligonucleotides were obtained from Biosynthesis (Lewisville, TX) at 250 nmol 
HPLC purity.  Seven 20-base pair oligonucleotides were used for these experiments.  
Oligonucleotides were reconstituted by first adding a volume of phosphate-buffered 
saline (PBS) equal to ten times the nmole amount.  5 µL of this solution was added to 995 
µL of PBS, and the absorbance of this new solution was measured at 260 nm using a UV 
Spectrometer.  The concentrations of the original reconstituted solutions were determined 
with Beer’s Law.  BSI stock solutions were set to 200 nM for the probe actin strand, 
whose sequence was derived from the mouse actin gene, and 500 nM for each binding 
strand.  BSI sample solutions were then made via serial dilutions, with the actin 
oligonucleotide (probe strand) serving as the receptor, with a concentration held constant 
at 100 nM and the binding oligonucleotide concentration varying from 0-250 nM.  These 
solutions were left to equilibrate overnight in a refrigerator before running experiments 
the next day. 
3.2.3. BSI experiments 
 Prior to starting experiments, the laser and temperature controller were allowed to 
warm up and equilibrate for approximately one hour.  The temperature of the BSI stage 
was held at 25 °C.  Experiments were conducted by pipetting 1 µL of buffer into the 
channel to check signal stability and repeatability, then each subsequent sample was 
injected, starting with the zero point (buffer and probe strand only) and data was 
collected for 1 min.  This helps to minimize noise from the initial baseline disruption 
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immediately following injection.  After each injection, the channels were cleared by 
vacuuming through the opposite well.  Blank, or reference, samples displayed no 
additional signal change from the buffer reference. 
One oligonucleotide with a complementary sequence of the actin probe strand and 
four strands containing one SNP were studied to obtain binding data: 1) an A/G mismatch 
located at the center of the sequence (Center Mismatch), 2) an A/G mismatch located 
halfway between the center and the end of the sequence (Quarter Mismatch), 3) a T 
deletion located at the center of the sequence (Center Deletion), and 4) a T deletion 
located halfway between the center and end of the sequence (Quarter Deletion).  One 
nonsense strand, in which no bases would match with the probe sequence, was used as a 
negative control.  The oligonucleotide sequences are listed in Table 1. 
Table 3.1.  DNA oligonucleotides studied.  Mismatched base pairs are bolded and 
underlined.  Deleted base pairs are indicated by their neighboring base pairs (bold and 
underlined). 
Strand 
 
Sequence 
Actin 
 
5’-ACTCATCGTACTCCTGCTTG-3’ 
Complement 
 
5’-CAAGCAGGAGTACGATGAGT-3’ 
Center 
Mismatch  
5’-CAAGCAGGAGGACGATGAGT-3’ 
Quarter 
Mismatch  
5’-CAAGCAGGAGTACGAGGAGT-3’ 
Center 
Deletion  
5’-CAAGCAGGAGACGATGAGT-3’ 
Quarter 
Deletion  
5’-CAAGCAGGAGTACGAGAGT-3’ 
Nonsense 
 
5’-ATGAGTACGATGGAGACGAC-3’ 
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3.2.4. BSI data analysis 
The data were analyzed and plotted with graphical software, and KD values were 
calculated from a one-site binding hyperbola equation (Eq 3 in Chapter 1).  Error in the 
KD was determined from the standard deviation of each data point as well as differences 
between the predicted values from the equation and the observed values, using an Excel 
Solver macro.  Each data point was subtracted from the zero point, that is, the sample 
with probe strand of actin present in buffer but no binding oligomer present.  Blanks 
containing only the binding oligomer featured no discernible signal above the noise level, 
and so were not used for zeroing the data.   
3.2.5. Hyperchromicity studies  
To correlate the BSI results with those from a more well-known and widely-
available method, melting transition temperatures for each duplex were determined using 
Circular Dichroism (CD) Spectroscopy.  The concentration of each duplex was 5 µM, 
and the samples were allowed to equilibrate at room temperature for at least one hour 
prior to experiments.  In these experiments, repeated thrice to determine standard error, 
the absorbance was measured at 260 nm while the temperature increased gradually (1 °C/ 
min) from 30 °C to 75 °C.  A higher melting transition temperature, indicative of stronger 
binding and duplex stability, was expected to correlate with a lower BSI KD value. 
3.3. Results and Discussion 
3.3.1. BSI binding results and KD values 
 The previous BSI experiments studying DNA hybridization featured 30-base pair 
sequences with the actin probe strand held constant at 150 nM.  A calibration of a duplex 
of the probe strand and its complement, shown in Figure 3.3, exhibited the expected 
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linear response of the signal (phase shift) with increasing concentration of duplex, and it 
was determined that for these experiments, the concentration of the probe strand could be 
lowered to 100 nM.  Greater error and deviation from the expected linear trend is seen at 
higher concentrations, where the expected linear signal response to concentration tends to 
break down likely due to aggregation, so experiments are designed to avoid product 
(duplex) concentration in those regions.   
 
Figure 3.3. Calibration of duplexed probe strand and complement. 
 
For all of these experiments, the signal returned to its approximate initial starting 
position (accounting for minor changes in environmental factors affecting signal) for the 
first sample after the final sample, containing the highest concentration of DNA, which 
indicated that the silanization was effective and no DNA was interacting with the surface 
to cause erroneous signals.  Upon completion of experiments in all three channels of the 
microfluidic chip, they were rinsed, sonicated, and resilanized for a fresh coating each 
time.  Individual binding curves for each duplex  are shown in Figures 3.4-3.9.  Each data 
point represents the average of at least five trials over three or more days, with error bars 
representing the standard error of the mean (SEM).  
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Figure 3.4. BSI binding curve of signal vs. concentration of binding strand, which has a 
complementary sequence to the probe strand. 
 
 
Figure 3.5. BSI binding curve of signal vs. concentration of binding strand, which 
contains a T deletion located four base pairs from the 3’-end of the oligomer. 
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Figure 3.6. BSI binding curve of signal vs. concentration of binding strand, which 
contains an A/G mismatch located four base pairs from the 3’-end of the oligomer. 
 
 
Figure 3.7. BSI binding curve of signal vs. concentration of binding strand, which 
contains a T deletion located in the center of the oligomer’s sequence. 
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Figure 3.8. BSI binding curve of signal vs. concentration of binding strand, which 
contains an A/G mismatch located in the center of the oligomer’s sequence. 
 
 
Figure 3.9. BSI plot of signal vs. concentration of samples containing a nonsense strand, 
a random sequence, in which little to no hybridization is expected. 
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Table 3.2. BSI KD values of oligomer duplexes. 
Duplex Binding 
Strand 
KD (nM) 
Complement 71.4 + 18 
Quarter Deletion 84.8 + 15 
Quarter Mismatch 139 + 38 
Middle Deletion 113 + 34 
Middle Mismatch 163 + 37 
 
The KD values of each duplex are listed in Table 3.2.  As expected, the 
complementary duplex had the lowest KD value, indicative of the strongest binding.  In 
addition to expecting the complementary duplex to exhibit the strongest binding, we 
anticipated the duplexes containing a SNP closer to the end of the sequence would be 
more stable than those containing a SNP in the middle of the sequence, as a centrally-
located SNP had the potential to disrupt a larger portion of the duplex compared to one 
nearer the end, and terminal mismatches have even been shown to stabilize binding, 
resulting in a lower KD value compared to the complementary duplex.
22,23
   
When comparing the KD values (Table 3.2) of both sets of similar SNPs, that is, 
the quarter and center deletions (KD’s of 84.8 and 113 nM), and the quarter and center 
mismatches (139 and 163 nM), this hypothesis is correct.  However, the center deletion 
still exhibited a lower KD value than the quarter mismatch (113 and 139 nM), indicating 
that the A/G mismatch had a greater destabilizing effect on the hybridized DNA than the 
T deletion regardless of location within the sequence.   
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3.3.2. CD melting temperature results and comparison to BSI 
 The melting transition profiles of absorbance at 260 nm versus temperature for 
each duplex are shown in Figure 3.10, and the Tm for each duplex is listed in Table 3.3 
along with its corresponding BSI KD. 
 
Figure 3.10. Melting transition profiles for DNA duplexes. 
 
Table 3.3. Tm of duplexes compared to BSI KD values. 
Duplex Binding Strand Tm (°C) KD (nM) 
Complement 68.7 + 0.3 71.4 + 18 
Quarter Deletion 59.0 + 0.5 84.8 + 15 
Quarter Mismatch 60.9 + 0.6 139 + 38 
Middle Deletion 56.5 + 1.4 113 + 34 
Middle Mismatch 52.0, 64.2 + 1.5 163 + 37 
 
The melting temperatures of the duplexes correlated with the BSI results, most 
notably with the complement duplex exhibiting the lowest KD value and the highest Tm, 
again indicating it is the most stable duplex tested in this study.  Likewise the quarter 
SNPs had a lower Tm than the complementary duplex but a higher Tm compared to the 
middle SNPs, indicating that more centrally-located SNPs have a greater destabilizing 
effect on the duplex affinity. This is graphically represented in Figures 3.11 and 3.12, 
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which examine at the comparison of KD and Tm values between the same SNP (deletion 
or mismatch) in different locations and the complement.   
 
Figure 3.11. Graphical representation of comparison of BSI KD values to CD Tm values 
of complementary duplex (●) with centrally located T deletion (♦) and quarter T deletion 
(■).  The more to the lower right the data point is, the stronger the binding affinity of the 
duplex. 
 
Figure 3.12. Graphical representation of comparison of BSI KD values to CD Tm values 
of complementary duplex (●) with centrally located A/G mismatch (lower Tm) (♦) and 
quarter A/G mismatch (■).  The more to the lower right the data point is, the stronger the 
binding affinity of the duplex. 
 
 
One notable exception was the center A/G mismatch duplex, which had the 
highest KD value of the duplexes studied (163 nM), indicating it was the least stable, 
however its main Tm was unexpectedly high (64.2 °C).  Upon closer examination, the CD 
melting profile seems to indicate that not just one complete melting transition was 
present, but instead two small melting transitions were present with a more gradual 
absorbance increase before the major melting transition (Figure 3.13). 
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Figure 3.13. Tm profile of the middle mismatch duplex showing two melting transitions. 
   
When graphically observing this lower melting transition temperature (52.0 °C) in 
Figure 3.13, the expected trend is much clearer.  This suggests that the oligonucleotides 
containing the central A/G mismatch may not form one duplex in equilibrium, but due to 
the ability of this mismatch to form up to four different hydrogen bonding patterns, plus 
the fact that this purine-purine pairing is too large for the typical helical backbone 
size,
24,25
 there may have been a more complex equilibrium of two or more duplex 
conformations present, for example one in which both bases are in the anti position, and 
one in which one is syn and one is anti; the structures of these possible conformations are 
shown in Figure 3.14.  
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Figure 3.14. Possible structures of an A/G mismatch pair. 
 
These conformations would result in duplexes that have different melting 
transition temperatures due to varying stabilities of the A-G hydrogen bonds and 
disruption to the overall shape of the duplex.  The instability of the duplex and variations 
in base-pair binding would also explain the larger KD values observed in the BSI 
experiments, and the potential for a more complex equilibrium between structures would 
also explain the larger error bars seen in the SNP binding curves compared to the 
complement.  These effects would also be less pronounced for the quarter mismatch 
duplex since they would not be occurring in the center of the duplex and thus disrupting a 
larger portion of the duplex.  And while the deletion of a T creates an A bulge upon 
hybridization, which is farther destabilized due to not being flanked by other A bases,
5
 
the bulge overall causes less disruption to the overall stability than the A/G mismatch. 
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3.3.3. Signal magnitude and FreeSRF of duplexes 
All DNA binding curves featured a positive binding curve for our specific 
detector’s orientation.  Calibration curves, both of glycerol and double-stranded DNA 
(dsDNA), show a phase shift that increases in the negative direction with increasing 
concentration, which correlates to an increase in optical density.  The hybridization of 
DNA duplexes causes an overall decrease in optical density and refractive index of the 
solution.  This is seen in the positive signal direction as binding occurs.  A decrease in RI 
has been shown to result from decreases in hydrodynamic radius,
26
 which would be 
expected as single-stranded DNA (ssDNA) hybridizes to dsDNA, decreasing the overall 
length with ‘accordion-like’ shrinking.27 
 
Figure 3.15.  Binding curves obtained with BSI for each DNA duplex. 
 
Additionally, the complementary duplex also exhibited the largest positive phase 
shift, or signal change, compared to the duplexes containing a SNP, as shown in Figure 
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3.15.  The signal of BSI is believed to derive from a variety of factors, including solvent 
displacement (solvent-accessible surface area, SASA) and structural changes (measured 
by radius of gyration, Rgyr),
26,28
 which alter the bulk optical density and refractive index 
of the solution.  This indicates that the complementary duplex has the largest bulk 
refractive index changes compared to the duplexes containing a SNP.  The Bornhop 
group has also correlated number of binding base pairs with signal magnitude,
29
 so this 
trend also fits our observations that the complementary duplex exhibits the strongest 
binding compared to the SNP duplexes that have greater disruptions to binding due to the 
unfavorable mismatch or base bulge.  Using the FreeSRF expression described in Chapter 
1.4, it is possible to calculate the molar refractometry, χexp, for each duplex.  
Table 3.4.  KD, Bmax, and χexp values of DNA duplexes. 
Duplex Binding 
Strand 
KD (nM) 
Bmax 
(radians) 
χexp (RIU/M) 
Complement 71.4 0.158 -1663.08 
Quarter Deletion 84.8 0.098 -1033.01 
Quarter Mismatch 139 0.114 -1195.37 
Middle Deletion 113 0.080 -845.40 
Middle Mismatch 163 0.117 -1232.42 
 
The KD, Bmax, and χexp values of each DNA duplex are listed in Table 3.4.  Bmax 
from the one-site binding hyperbola equation is equal to the maximum possible signal 
from the maximum concentration of dsDNA.  Since the receptor probe strand is held at 
100 nM, CBmax of the dsDNA would be 100 nM.  The complement duplex has at least a 
35% higher signal compared to the other duplexes containing a SNP.  The signal 
magnitude, and thus χexp, does not follow the same trend as the KDs for each duplex, 
however.  Despite being the most destabilized, the mismatched duplexes have a higher 
signal and χexp than the deletion duplexes, at 0.114 and 0.117 radians compared to 0.098 
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and 0.080 for the deletions.  This indicates that despite forming a weaker duplex, the 
dsDNA containing an A/G mismatch exhibit greater changes in RI upon hybridization. 
Molar refractometry, χexp, is a term that encompasses the changes in an analyte’s 
intrinsic properties.  When testing the validity of the FreeSRF expression, Bornhop and 
coworkers modeled χ values based on Rgyr and SASA, and developed fitting coefficients 
with training sets to compare modeled and experimental χ’s.26  This training set was 
divided into two arbitrary subsets: large and small, based on the χexp of the training set 
systems. The χexp values for the duplexes in this study fall into a range that were included 
in the large training set (|782-1379| RIU/M), but saw significant (>200%) error with the 
fitting coefficients, suggesting that an intermediate set of coefficients might be preferable 
for χexp values in this range (the authors also acknowledged that the training model could 
be fit into more subsets, and most likely will be as more training set systems are added).  
An added challenge for determining ∆Rgyr of going from ssDNA to dsDNA could also 
involve the overall shape of the molecules; where proteins tend to be mostly globular, 
DNA strands are more flexible and cylindrical or chain-like in shape. 
Additionally, one intrinsic property that could likely play an important role in 
DNA hybridization that is presently unaccounted for in the FreeSRF model is 
polarizability.  Fumagalli and coworkers examined this property of dsDNA and 
discovered the dielectric constant of dsDNA, εr, is significantly higher than originally 
assumed, with a value of ~8 as opposed to the low polarizability of proteins to which it 
was usually compared (εr ~ 2-4).
30
  This high polarizability is attributed to the high charge 
on the backbone and the π-stacking along the inside of the helix.  A base bulge looped-
out of the helix could have a more significant impact on a duplex’s polarizability 
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compared to a mismatch since the mismatch still retains all of the bases within the 
backbone of the helix. 
Taking the KD results and the signal magnitude, or χexp, together, we have shown 
that stronger DNA duplex binding generates a greater change in RI compared to weaker 
binding in duplexes containing a SNP. This is reasonable because mismatched base pairs 
disrupt hybridization and can have different configurations that are not as strong due to 
helical constraints or unfavorable hydrogen bonds; in particular, the A/G mismatched 
bases used in this experiment have been shown to have up to four different hydrogen 
bond configurations.
24,25
 
Similarly, a sequence containing a deletion would create a small bulge in the 
oligonucleotide so the remaining bases may bind, which would disrupt the overall 
hybridization.
31
  These factors negatively affect the stabilities and structures of the 
duplexes, and decrease the number of binding events in the duplex.
29
  With less stability, 
lowered polarizability, and fewer binding base pairs within the structure of the helix, a 
smaller signal shift would be observed. Conversely, the complementary duplex would 
have the largest amount of bound bases, a greater degree of change in conformation to 
accommodate the binding of those bases, and higher polarizability due to undisrupted π-
stacking of the complementary bases.  These factors lead to stronger binding and a larger 
phase shift.   
3.4. Conclusion 
BSI has the ability to distinguish a 20-base pair DNA duplex formed with a 
complementary oligonucleotide from various oligonucleotides containing one SNP, either 
a deleted base (G) or an A/G mismatch.  Additionally, BSI was able to distinguish 
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between duplexes containing a mismatched or deleted base pair, as well as between 
duplexes with a given SNP in different locations in the sequence, based on the binding 
affinity of each duplex measured as a KD value.  Specifically, these results showed that 
(1) a centrally located SNP was more destabilizing than that same SNP located closer to 
the end of the sequence, (2) an A/G mismatch had a greater impact on destabilization 
than a T deletion regardless of their location in the sequence, and finally (3) the 
complementary duplex featured a larger signal magnitude (in the positive direction) 
compared to duplexes containing SNPs, which was attributed to the greater number of 
favorably-interacting base pairs.   These results correlated with a more commonly 
employed method, measuring melting transition temperatures using CD, and highlight 
BSI’s excellent sensitivity in its ability to detect seemingly small differences between the 
type of SNP present and different locations separated by just four bases out of twenty.   
Previous experiments have shown that BSI is capable of distinguishing a 
complementary, 30-base pair duplex from a duplex containing two centrally-located 
mismatches with a probe strand concentration of 150 nM.
22
  The present experiment used 
shorter sequences to be more consistent with other types of research employing short 
DNA sequences to examine hybridization (typically 18-24 bp oligonucleotides),
15–19
 and 
a probe strand held at 100 nM, while the binding strands varied in concentration from 25 
nM up to 250 nM.  Considering the probe volume of the instrument (7.52 nL), this 
equates to measuring 113,000,000 binding strand molecules.  This probe volume is orders 
of magnitude lower than other techniques; SNP detection studies with Molecular Beacons 
used 25 µL with concentrations of 200 nM,
19
 and techniques with SPR required flow 
rates of 20-30 µL/min at similar concentration ranges (10-100 nM).
17
  Using gold 
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nanoparticles, SNPs have been detected at concentrations of oligonucleotides as low as 
2.5 nM, but this required several hours of sample preparation, and used tags on the 
oligonucleotides.
16
  BSI’s main advantages lie in its ability to detect a variety of SNPs at 
similar, low concentrations in their natural (free solution and label-free) state at 
physiological conditions, relying solely on the hybridization of a duplex to generate a 
signal.  
The source of the BSI signal is attributed to bulk changes in solution which alter 
the refractive index, or optical density of the solution, including conformation changes, 
such as the formation of the helical duplex, and solvation, as the solvent molecules 
surrounding the oligonucleotides are expelled as they interact and form the base pair 
hydrogen bonds.  We observed a much higher signal in the complementary duplex 
(>35%) compared to the four SNP duplexes, which we attributed to the stronger binding 
and higher number of base pairs able to interact with their complement.  Similarly, 
Bornhop and coworkers have observed that the magnitude of the BSI signal increases as a 
duplex is converted from its native B-form to A-form or with DNA:RNA hybrids.
29
  We 
also discuss potential additional considerations to the FreeSRF model to accurately 
account for DNA hybridization as it has with protein systems, including accounting for 
the unexpectedly high polarizability of dsDNA. 
The low concentrations and small amount of sample required for a BSI 
experiment (1 µL injections), and the ability to perform these experiments label-free and 
in free solution make BSI a viable instrument for detecting SNPs.  BSI has also been 
shown to work with full serum samples,
32
 so our hope is that in the future, 
commercialized instruments will be widely available for use in both rapidly detecting 
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SNPs in a target region, and for diagnoses for conditions and diseases impacted by 
certain SNPs.   
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Chapter 4 
Potassium Ionophore studies with BSI and evaluation of FreeSRF in nonaqeuous, 
small molecule, ion-recognition systems 
 
4.1. Introduction 
 Most BSI experiments measure large molecule interactions, such as proteins or 
DNA with a ligand, but these interactions are driven by many smaller interactions, such 
as hydrogen bonds or ion interactions.  Such interactions have been measured in a myriad 
of systems using several techniques, including NMR,
1
 fluorescence,
2
 and calorimetry.
3
  
As previously discussed, BSI offers several advantages to these techniques, including its 
small sample size and ability to perform binding assays in free solution.  Additionally, 
with the development of the FreeSRF expression, the source of the BSI signal has been 
described in terms of conformational and solvation changes of the product or complex of 
the binding interaction.
4
  This has only been done, however, with large biomolecular 
systems.  Smaller binding systems with organic molecules would have a much smaller 
conformational change, but have been shown to still produce a measurable signal.
5
  
Therefore the experiments in this chapter were designed to measure the BSI signal in 
small ion-recognition systems in nonaqaueous media in order to compare the signal in 
systems with large conformational and solvation changes (∆Rgyr and ∆SASA) to those in 
small, organic molecule systems.  The first experiment involved a very well-
characterized system, a crown ether with potassium ion, and subsequent systems featured 
three different potassium ionophores. 
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4.1.2.  Metal Complexes with Crown Ethers 
 Crown ethers are a class of cyclic polyethers whose abilities to form stable 
complexes with various cations, depending on the size of the crown and the cation, were 
first discovered by C. J. Pedersen in 1967.
6
  He first noticed a small amount of white, 
crystalline byproduct in a preparation of bis[2-(o-hydroxyphenoxy)ethyl]ether 
contaminated with a small amount of catechol.  The cyclic polyether was coined dibenzo-
18-Crown-6 and was found to form stable 1:1 complexes with several alkali and alkali-
earth metal salts.  Pedersen continued this research with both known and novel cyclic 
polyethers to demonstrate a wide variety of crown ethers and compare their complexing 
properties.  Selectivity is based on the size of the cation and the size of the cavity in the 
crown ether; affinity is based on the coplanarity of the crown, the number of oxygen 
atoms in the ring, and the distance between each of those oxygen.   
      
Figure 4.1. A) Dibenzo-18-Crown-6, B) Complex of 18-Crown-6 and K
+
.
7
  
 
Pedersen coined the shortened “crown” names based on their ability to “crown” 
the cation with the oxygen in the ring in an ion-dipole interaction as shown in Figure 4.1, 
with the first number indicating the total atoms in the polyether ring, and the second 
indicating the number of oxygen atoms in the ring.  For example, the compound with the 
A) B) 
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standard IUPAC name 1,4,7,10,13,16-hexaoxacyclooctadecane is referred to as 18-
Crown-6 (18C6).  Table 4.1 lists the three simplest crown ethers and the cation for which 
they have the highest affinity. 
 
Table 4.1. Crown ether structures and coordinating cation. 
Structure 
 
 
 
Name 12-Crown-4 15-Crown-5 18-Crown-6 
Selecive 
Cation 
Li
+
 Na
+
 K
+
 
 
 Since Pedersen’s discovery of their unique binding properties, crown ethers’ 
chemistry and applications have become an important area of research.  Saturated crown 
ethers are able to solubilize inorganic salts in aromatic hydrocarbon solvents such as 
benzene and toluene, making them useful phase transfer catalysts and ion-selective 
electrodes (ISEs).
8–10
  The fields of molecular design and host-guest chemistry developed 
out of crown ether research, and other molecular families such as calixarenes and 
cryptands were introduced as a result.
11
  Crown ethers, as well as other host-guest 
receptors, can also serve as synthetic ionophores for membrane transport, mimicking the 
function of natural ionophores in cells.   
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4.1.3. Valinomycin as a Potassium-selective Ionophore 
 An ionophore is a compound that selectively and reversibly binds a cation for 
transport through hydrophobic media; for naturally-occurring ionophores this includes 
cell transport through membranes or liposomes.  Valinomycin (Vm) is one such 
ionophore that is highly selective for potassium over sodium in Streptomyces bacteria.  It 
is a dodecadepsipeptide that contains three oligomers of L-valine (L-Val), D-α-
hydroxyisovaleric acid (D-Hv), D-valine (D-Val), and L-lactic acid (L-Lac), shown in 
Figure 4.2. 
  
Figure 4.2. A) Valinomycin structure. B) Repeating depsipeptide component that 
produces the cyclic Valinomycin structure. 
 
 Many studies have been performed to study the structure of free and complexed 
Valinomycin since its discovery in the 1960s, using NMR, Raman spectroscopy, 
computer simulations, and more.
12–15
  Like the crown ethers, the cavity is one of the main 
factors in its ion selectivity for potassium, which has a radius of ca. 1.33 Å, however, 
complexes with other cations have been observed, occasionally with stoichiometries of 
1:2 or 2:1 and different conformations.
16,17
  Additionally, the structure of free 
valinomycin has shown a large degree of solvent dependence, based on solvent polarity 
and hydrogen bonding.
14,18
  Upon binding, the valinomycin-potassium complex takes on 
A) B) 
 106 
a “tennis ball seam” conformation as shown in Figure 4.3 regardless of solvent effects.  
The six ester carbonyls point into the cavity to bind the potassium ion, and the amide 
hetero atoms of the amides stabilize the conformation through intramolecular hydrogen 
bonds. 
 
Figure 4.3. Structure of valinomycin-K
+
 complex from DFT simulations viewed from A) 
above and B) side.  Hydrogen atoms are omitted except those taking part in internal 
hydrogen bonds (distances labeled in Å).
19
 
  
 Valinomycin acts as a potassium ionophore based on its ability to form a lipid-
soluble complex due to the hydrophobic methyl and isopropyl groups facing outwards 
from the cavity (as seen in Figure 4.3).  The complex is unstable in hydrophilic or 
aqueous environments, so the ion is released once the complex crosses the membrane.
14,20
  
This function gave rise to several synthetic ionophores which behave similarly, most 
often for use in ISEs, and valinomycin is also known as Potassium Ionophore I. 
4.1.4. Bis(crown ether) ionophores 
 Pedersen’s discovery of the crown ethers’ complexation abilities and 
Valinomycin’s conformational changes upon complexation motivated scientists to 
develop other types of selective ionophores, of which one group of compounds was 
A) B) 
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developed known as bis(crown ether)s.
21,22
  Bis(crown ether)s feature two crown ether 
moieties connected by an alkyl chain.  They form an intramolecular complex with a 
cation by sandwiching it between the two crown ether faces; this complex has been 
likened to a clamshell.  An example is shown in Figure 4.4A. 
 
Figure 4.4. (A) Representative bis(benzo-15C5), and (B) diagram of the “closed 
clamshell” complex with potassium.21 
 
Inoue and coworkers developed a series of bis(benzocrown ether)s to examine 
this complexation and noted that in many cases the internal “1:2” complexation of the 
cation to both crown ether ends was more stable than the mono crown ether.
21,23
  The ion 
complexing with two crown ethers also meant that different sized crown ethers fit a 
cation compared to the mono crown ether; in the case of potassium ion, the 1:2 complex 
that fits best is made of two 15-crown-5 moieties.  They also noted that the linker length 
affected complex stability.  Too short a chain resulted in an “open clam” complex that 
had incomplete desolvation of the potassium ion, and too long a chain resulted in greater 
degrees of freedom in the chain and complex conformation.
21
   
Other researchers such as Tóth and coworkers modified bis(benzo crown ether)s 
for improved ISEs by adding alkyl chains to the linker and electron withdrawing groups 
to the benzyl groups.  These modifications produced improved stabilities with the 
electrode membranes and increased selectivity for potassium over sodium.
22
  While the 
complexation between cation and crown ether oxygen for these types of bis(benzo crown 
A) B) 
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ether)s is analogous to the mono crown ethers that Pedersen studied, thermodynamic 
studies showed that these ionophores undergo a more significant conformational change 
upon complexation similar to valinomycin.
23
 
4.1.5. Previous nonaqueous, small molecule experiments with BSI 
 To determine if BSI free-solution measurements could be extended to 
nonaqueous, small molecule interactions, experiments were designed to measure 
hydrogen bonding affinities between tetramethylammonium benzoate (TMAB) and 1,3-
diphenyl urea (DPU), 1,3-diphenylthiourea (DPTU), 1,3-bis(p-nitrophenyl)urea (DNPU) 
and 1,3-bis(p-nitrophenyl)thiourea (DNPTU).
5
  These compounds were chosen based on 
their well-characterized ability to form strong hydrogen bonds, an example of which is 
shown in Scheme 4.1, as well as their utilization in organic reactions.
24,25
 
 
Scheme 4.1. Hydrogen bonding between DPU/DPTU (X = H) or DNPU/DNPTU (X = 
NO2) and TMAB. 
 
 The para-substituted nitro groups on the phenyl rings in DNPU and DNPTU 
serve to draw electron density away from hydrogen, increasing their acidity and resulting 
in a stronger hydrogen bond. 
 Acetonitrile (MeCN) was chosen as the solvent for two main reasons: 1) it can 
readily dissolve the chosen compounds at concentrations necessary for benchmarking 
with ITC (mM range), and 2) its RI is close to H2O (η = 1.342 and 1.332, respectively).  
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The RI of the solvent must not be too close to that of the glass used in the microfluidic 
chip (η = 1.517) in order to generate a high-contrast fringe pattern, for example, DMSO’s 
RI of 1.476 is too close to generate an acceptable fringe pattern. 
 BSI results are summarized in Table 4.2.
5
  Results correlated well with ITC 
experiments.  Additionally, they indicated little difference between ureas and thioureas, 
and a stronger binding affinity between the para-nitro-substituted compounds than the 
unsubstituted as expected (KD’s of 0.54 and 0.42 µM vs 18.56 and 23.20 µM). 
 
Table 4.2. BSI and ITC results of TMAB complexes with ureas and thioureas.
5
 
TMAB 
Complex 
BSI KD (μM) ITC KD (μM) 
DPU 18.56 + 4.46 21.75 + 6.04 
DPTU 23.20 + 4.55 27.43 + 3.72 
DNPU 0.54 + 0.08 1.26 + 0.06 
DNPTU 0.42 + 0.08 1.18 + 0.17 
 
 The ability to perform nonaqueous experiments meant that entire new groups of 
systems could be studied with BSI.  No conformational change occurs between TMAB 
and DPU (and others) when the two hydrogen bonds are formed; solvation effects, 
specifically the displacement of solvent molecules during hydrogen bond formation, are 
the main contributors to the BSI signal.  Unsurprisingly, the magnitude of the signal is 
much smaller compared to those from larger, biomolecular systems such as protein-
ligand or DNA duplexes. 
4.1.6. Designing BSI experiments for metal ion recognition 
 Host-guest recognition systems such as the crown ethers and other ionophores 
represent another type of binding with small molecules that we hypothesized could be 
observed via BSI.  18C6 complexing with potassium would not be expected to undergo a 
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significant conformational change, but ionophores like the bis(benzocrown ether)s 
undergoe a conformational change to form the “closed-clam” complex in a way that 
mimics some larger systems, such as calcium-CaM binding to a ligand (recall Figure 
1.14C).  Comparing the resulting signals from BSI experiments with 18C6 and other 
ionophores could provide more insight into the source of the BSI signal, particularly for 
small molecule systems where conformational changes might not have as large an impact 
as they do in large biochemical systems.  
4.1.7. Expanding the FreeSRF expression into nonaqueous, small molecule systems 
 Thus far the systems evaluated with the FreeSRF expression featured large 
biomolecules and their ligands, which undergo significant conformational changes upon 
binding.
4
  The hydrogen-bonding systems examined previously with BSI demonstrated 
that a measurable binding signal can be obtained even for small molecule systems that 
lack the molecular weight and large conformational changes seen in the biochemical 
systems.  The signal from the TMAB-DPU systems was hypothesized to arise from 
solvation changes as the hydrogen bonds form.  Signals arising from the ion-recognition 
systems would also be expected to have a larger impact from solvation compared to 
biomolecular systems.  Signal changes in these smaller systems could be analyzed to 
refine the FreeSRF expression for small organic molecules. 
 
4.2 Materials and Methods 
4.2.1. Instrument and chip preparation 
 The instrument was equilibrated for at least one hour prior to experiments.  The 
temperature-controlled stage was held at 25 °C.  The microfluidic chip (210 μm diameter 
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channels) was used with no silanization or other surface treatment.  Channels were rinsed 
with MeCN after each experiment, and after all three channels were used (typically 5-7 
trials per channel), they were filled with H2O and sonicated for 30-40 min, then rinsed 
with H2O and MeCN, vacuumed dry, and secured in the stage. 
4.2.2. Preparation of samples 
 Four ionophore receptors were used in this study: 18-Crown-6 (18C6), Potassium 
Ionophore I (or Vm), Potassium Ionophore II (Figure 4.5A), and Potassium Ionophore III 
(Figure 4.5B), all obtained from Sigma-Aldrich.  The salt used for each ionophore was 
potassium iodide (KI) due to its higher solubility in MeCN than other potassium salts 
such as KBr or KCl.  Sodium iodide (NaI) was also used with 18C6 to observe the 
difference between a high-affinity ion and a low-affinity ion. 
 
Figure 4.5. A) Potassium Ionophore II and B) Potassium Ionophore III 
 Ionophores II and III, 18C6, and KI were dried under vacuum overnight before 
dissolving in MeCN.  The initial KI solution and Ionophore III solution were each 
sonicated for ca. 5 min to ensure complete dissolution.  Stock Vm solutions were stored  
in a refrigerator at 4 °C.  KI and NaI stock solutions and BSI samples were kept covered 
with foil to prevent light-induced decay of iodide. 
A) B) 
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 In each BSI experiment, the ionophore acted as the receptor and was held at a 
constant concentration while KI was the ligand with varied concentrations.  
Concentration ranges were determined based on ITC Ka results. 
4.2.3. ITC Experiments 
For the ionophore experiments, both the reference and sample cells were rinsed 
three times then filled with degassed MeCN.  The syringe was rinsed with degassed 
MeCN by drawing liquid through the mixing needle.  Blank trials were performed to 
subtract any significant heats of dilution from the binding heats.   
For all ITC experiments, the reference power was set to 20 µCal/sec and the cell 
temperature to 25 °C. 25-30 injections of 10.0 µL each were performed with a spacing of 
360 sec (later reduced to 180 sec).  10.00 mM 18-Crown-6 was titrated into 1.00 mM KI.  
Potassium Ionophore II experiments were conducted at the same concentrations as 18C6.  
Potassium Ionophore III is less soluble in MeCN compared to 18C6 and Ionophore II, so 
2.0 mM KI was titrated into 0.2 mM Ionophore III.  Potassium Ionophore I also used 2.0 
mM KI titrated into 0.2 mM Ionophore due to a more exothermic interaction compared to 
the other ionophores.  Binding isotherms were fit using Origin software to obtain the 
stoichiometry, Ka, ∆H, and ∆S. 
4.2.4. BSI Data Collection 
For each BSI experiment, the ionophore was held at a constant concentration 
while the concentration of KI was varied, and KI reference samples were subtracted to 
obtain the binding curve.  Samples were prepared in glass vials and allowed to equilibrate 
for ca. 30 minutes, and were kept covered with foil when not running experiments.  
Concentration ranges were determined based on the ITC KD values.  18C6 and Ionophore 
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II were set to 7.5 µM with KI (or NaI) going up to 10 µM.  Ionophore III was held at 1.5 
µM with KI going up to 2.5 µM.  Ionophore I was held at 100 nM with KI going up to 
300 nM.   The channels of the glass chip were not silanized.  The injection volume for 
each experiment was increased to 2.00 µL.  Data were collected for ca. 15-20 sec; the 
shorter collection time and larger volumes were due to MeCN’s much faster evaporation 
rate compared to aqueous systems that would cause greater signal drift. 
4.2.5. BSI Data Analysis 
As described in previous sections (2.2.4 and 3.2.4), binding curves were plotted as 
a function of phase shift versus ligand (ion) concentration in Excel, and a KD was 
calculated from the one-site rise to max binding hyperbola equation using Solver.  Error 
in KD was determined using a solver macro.  FreeSRF χexp values were calculated as 
previously determined (3.3.3).  χmodel values were calculated as described by Bornhop and 
coworkers using the following equation:
4
 
χ
     
                                           (1) 
Where A, B, C, D, and E are the small training set fitting coefficients,  ∆SASA is 
the change in solvent accessible surface area between bound and free receptor, aveSASA 
is the average SASA of bound receptor (in the case of some larger systems with minor 
changes between structures; for the ionophores only one structure was used), ∆Rgyr is the 
change in radius of gyration between bound and free ionophore and aveRgyr is the average 
radius of gyration of bound receptor.  Rgyr was determined for all structures with a 
Chimera script, and SASA was found for all structures using MGLtools.  Structures for 
the free ionophores were put into Chimera using their SMILES code, structures for bound 
18C6 and ionophore I were obtained from the Cambridge Crystallographic Database, and 
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the structure of bound ionophore II was built using Gaussian and previously calculated 
strontium ionophores. 
 
4.3. Results and Discussion 
4.3.1. ITC Results 
The binding data for each ionophore with KI are shown in Figures 4.6-4.9.  The 
KD values were calculated as KD = 1/Ka.   
 
Figure 4.6.  ITC curve of 10.00 mM 18C6 into 1.00 mM KI. The average KD from three 
replicate experiments was 2.35 + 0.11 µM, and ∆H = -4389 + 56 kcal/mol, ∆S = 11.0 + 
0.2 cal/molK. 
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Figure 4.7.  ITC curve of 10.0 mM Potassium Ionophore II into 1.00 mM KI. The 
average KD from three replicate experiments was 2.81 + 0.29 µM, and ∆H = -6183 + 88 
kcal/mol, ∆S = 4.65 + 0.41 cal/molK. 
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Figure 4.8. ITC curve of 2.0 mM KI into 0.2 mM Potassium Ionophore III. The average 
KD from three replicate experiments was 2.42 + 0.21 µM, and ∆H = -13893 + 615 
kcal/mol, ∆S = -20.9 + 2.1 cal/molK. 
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Figure 4.9. ITC curve of 2.0 mM KI into 0.20 mM Potassium Ionophore I.  The average 
KD from three replicate experiments was 0.374 + 0.074 µM, and ∆H = -11057 + 378 
kcal/mol, ∆S = -7.64 + 1.2 cal/molK. 
 
 
4.3.2 BSI Binding Results 
The binding curves for the ionophores with KI are shown in Figures 4.10-4.13.  
All except Potassium Ionophore III had a single rise-to-max curve in the negative 
direction.  The binding curve for 18C6 with NaI is shown in Figure 4.14.  18C6 has a 
much weaker affinity for Na
+
 compared to K
+
 due to its smaller ionic radius. 
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Figure 4.10. BSI binding curve of 18C6 with KI.  [18C6] = 7.5 µM, and [KI] ranged 
from 0 – 10 µM.  KD = 3.20 + 0. 69 µM, Bmax = 7.78 mRad. 
 
 
Figure 4.11. BSI binding curve of Potassium Ionophore II with KI.  [Ionophore] = 7.5 
µM, and [KI] ranged from 0 – 10 µM.  KD = 2.79 + 0. 51 µM, Bmax = 10.7 mRad. 
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Figure 4.12. BSI binding curve of Potassium Ionophore I (Vm) with KI.  [Ionophore] = 
150 nM, and [KI] ranged from 0 – 300 nM.  KD = 66.7 + 16.4 nM, Bmax = 10.8 mRad. 
 
 
Figure 4.13. BSI binding curve of Potassium Ionophore III with KI. [Ionophore] = 1.5 
µM, and [KI] ranged from 0 - 2.5 µM.  Treating the positive binding curve portion as an 
isolated curve gives a KD = 0.279 µM and a Bmax of 6.60 mRad. 
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Figure 4.14. BSI binding curve of 18C6 with NaI.  Very little signal above the noise 
level is observed, too little to calculate a possible KD. 
 
4.3.3. Comparison of Signal Magnitude  
 The signal generated from these small molecule interactions is significantly 
smaller than those generated from binding of larger, biomolecular systems.  The signal of 
the Valinomycin-potassium binding curve was more than an order of magnitude smaller 
than the complementary dsDNA binding featured in Chapter 3, and both experiments 
were run at similar concentration ranges of both receptors and ligands (< 300 nM).  
Figure 4.15 features both of these curves to highlight the powerful sensitivity of BSI to 
detect these small-molecule interactions. 
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Figure 4.15. BSI binding curves of complementary dsDNA (violet) and VmK
+
 (red) 
(phase shifts are absolute value since these systems featured signals in opposite 
directions.) 
 
When comparing the binding curves of 18C6 with potassium and sodium at the 
same concentrations in Figure 4.16, a significant difference in the signal magnitude is 
observed, specifically, the signal from sodium-18C6 complex is barely above the noise 
limit of the instrument.  A sodium ion’s radius is ca. 0.4 Å smaller than potassium’s, 
making it too small to fit in the crown cavity (it is a much better fit for 15C5), so only a 
very weak interaction can be detected.  
 
Figure 4.16. BSI binding data of Na
+
 with 18C6 (♦), K+ with 18C6 (■), and K+ with 
ionophore II (▲). [18C6] and [ionophore II] = 7.5 µM. 
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Both 18C6 and Potassium Ionophore II had very similar affinities for K
+
 (3.20 
and 2.79 µM respectively) and ITC data correlated well with these values.  Their signal 
magnitudes, however, were very different, as highlighted in Figure 4.15.  From the rise-
to-max equations, the Bmax, or maximum signal generated, is 10.7 mRad for Ionophore II 
and 7.78 mRad for 18C6.  This is a percent difference of 31.6%.  The FreeSRF 
expression describes the source of the BSI signal as deriving from conformational 
changes and changes in solvation.  Based on this, the differences in the signal magnitude 
of potassium binding to 18C6 or to Ionophore II can be explained. 
Unbound 18C6 has been shown to take on slightly different conformations 
depending on potential interactions with solvent.
26
  In polar protic solvents, including 
water, its conformation is more constrained due to hydrogen bonds with the ether oxygen, 
and it tends to take on the D3d conformation.  Conversely, in aprotic solvents like MeCN, 
it is more flexible and can adopt other conformations, with Ci or S6 being 
computationally the lowest energy conformations.
26
  Some of the lowest calculated 
energy conformations of free 18C6 are shown in Figure 4.17.   
 
Figure 4.17. Structures of calculated lowest-energy conformations of free 18C6.
26
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When bound to the potassium ion, 18C6 tends to take on a D3d conformation.
27
  
Comparing this structure to the S6 and Ci conformations, as shown in Figure 4.18, allows 
one to visualize the relatively minor conformational changes that occur upon binding to 
the metal ion. 
 
Figure 4.18. Free 18C6 in the S6 and Ci conformation compared to a top and side view of 
18C6-K
+
 complex (D3d conformation).
28
 
 
 
Regardless of the conformation of the free crown, only a modest conformational 
change occurs upon binding, and the BSI signal is smaller as a result.  The 
conformational change that occurs when ionophore II binds to potassium to form the 
closed-clam structure produces a larger BSI signal, even when both receptors have very 
similar affinity for potassium ion. 
Figure 4.19 compares the signals of ionophore II and ionophore I (Vm).  
Ionophore I had a significantly stronger affinity for potassium ion (66.7 nM vs. 2790 
nM), but when plotting the signal phase shift as a function of molar ratio of potassium to 
ionophore, their resulting signals were very similar in magnitude, with a Bmax of 10.7 and 
10.8 mRad and a percent difference of less than 1%.  Both undergo significant 
conformational changes upon binding, with ionophore II forming the closed clam shell 
 124 
around the ion, and ionophore I forming the tennis-ball seam around the ion. This 
comparison highlights how BSI signal is affected by intrinsic structural changes (χ) and 
not simply strength of the interaction. 
 
Figure 4.19. BSI binding curves of phase shift vs molar ratio of K
+
 for ionophore II (∆) 
and ionophore I (□). 
 
 
18C6, ionophore I, and ionophore II binding to potassium all featured a negative 
phase shift relative to the instrument’s alignment (rotating the camera 180° will reverse 
the signal direction).  The direction of the BSI signal is related to a decrease or increase 
in optical density, and thus RI.  In the present set-up used in this thesis, a negative signal 
correlates to an increase in optical density and RI, while a positive signal is due to a 
decrease in RI, thus each of these ionophores have an overall positive ∆RI upon binding 
with potassium ion. 
4.3.4. Evaluation of FreeSRF in small molecule, nonaqueous systems 
As with the DNA systems, χexp was calculated for the potassium complexes of 
18C6, ionophore II, and ionophore I from the maximum signal, Bmax, the concentration of 
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the complex, and β, the instrument response function of our instrument, according to the 
FreeSRF expression discussed in Chapter 1.4.2. and shown below.   
 
            (1) 
 
Next, χmodel was calculated for each potassium complex using the smaller training 
set coefficients determined by Bornhop and coworkers.
4
  The results are summarized in 
Table 4.3. 
 
Table 4.3. χ values and FreeSRF parameters for potassium complexes of 18C6 and 
ionophores I and II. 
 
Potassium Complex 
 
18C6 
Ionophore 
I 
Ionophore 
II 
∆Rgyr (Å) -0.302 -0.416 -0.349 
∆SASA  (Å2) 1.17 27.06 -61.931 
χmodel 
(RIU/M) 
-616.67 -541.10 -560.13 
χexp (RIU/M) 1.09 75.48 1.49 
[Complex] 7.5 μM 150 nM 7.5 μM 
 
There was very poor agreement between χexp and χmodel, however, the difference 
between χexp of ionophore I and 18C6 is 74.4 RIU/M and the difference between χmodel of 
ionophore I and 18C6 is 75.6 RIU/M, remarkably good agreement.  This initial 
observation encouraged us to calculate a pseudo-structure for bound ionophore II, as a 
crystal structure was unavailable in the literature.  The structure is shown in Figure 4.20.  
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Figure 4.20.  Modeled structure of bound potassium ionophore II (oxygen in red, 
hydrogen not shown). 
 
This structure provided the calculations for Rgyr and SASA, and while its χmodel 
did not match up in the way that the difference between ionophore I and 18C6 complexes 
did, it was still between the two values.  The differences are highlighted in the number 
line in Figure 4.21. 
 
Figure 4.21. Depiction of differences between experimental and modeled χ values when 
both 18C6 experimental and modeled are zeroed. 
 
 The differences can likely be explained by the model coefficients A-E, which 
were all determined using large biochemical systems in aqueous media.  With more 
training set systems similar to the non-aqueous small molecule ones, a new set of “extra 
small” coefficients could be determined via a regression analysis.  Model structures of 
small organic molecules can be more easily analyzed and calculated compared to large 
biomolecules such as proteins or nucleic acids, which will allow for more thorough 
refinement of the FreeSRF expression. 
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4.3.5. Ionophore III signal changes 
 ITC data of potassium binding to ionophore III revealed that the binding affinity 
of ionophore III was similar to that of ionophore II, indicating that the hydrocarbon tail or 
the presence of the nitro groups had little effect on the strength of the potassium 
interaction with the crown moieties.  The alkyl tail was included in this ionophore to help 
improve its stability in the electrode membranes in which they were designed to be 
used.
22
  In contrast, however, the BSI binding data of potassium to ionophore III 
produced very different results compared to the other ionophores that generated a basic, 
hyperbolic binding curve, so it appears the inclusion of the hydrocarbon tail has a 
significant impact on the BSI signal. 
 Figure 4.13 shows the BSI binding data of ionophore III with potassium.  An 
initial decrease in phase shift is observed of ca. 10 mRad.  The signal then changes 
direction and saturates as a typical binding curve in the positive direction with a 
maximum signal of ca. 6.6 mRad above the minimum.  The initial decrease thus has the 
largest signal change of the system, and occurs when [K
+] = 0.400 μM.   
 Gestwicki and coworkers used SPR experiments to correlate changes in RI to 
changes in hydrodynamic radius, specifically, an increase in hydrodynamic radius (Rh) 
resulted in an increase in RI, and a decrease in Rh resulted in a decrease in RI.
29
  Based 
on this information, it appears the ionophore undergoes conformational changes upon 
binding to potassium ion that first increase its Rh but ultimately results in an overall 
decrease of Rh.  Since this effect isn’t observed in the other clamshell-binding ionophore 
II, the hydrocarbon tail of III is likely the source of the observed inconsistency. 
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Figure 4.20. 3D Stick model of free potassium ionophore III, with carbons in tan, 
oxygens in red, and nitrogen in blue (hydrogen not shown). 
 
 The structure of unbound ionophore III is shown in Figure 4.20.  Since the 
binding signal initially goes in the negative direction like the other ionophores, the 
conformational changes occurring begin with an increase in Rh, perhaps with the dodecyl 
tail being more extended from the crown ends.  The difference with ionophore III, then, is 
that upon complexation and saturation with potassium, the bound form’s conformational 
change results in a decreased Rh and RI, perhaps due to the dodecyl tail folding closer to 
the closed-clamshell crown ends.  The signal does not saturate above the starting point of 
unbound ionophore III, so while binding seems to cause an initial increase (positive ∆RI) 
followed by a decrease in RI (negative ∆RI), the overall ∆RI is positive. 
4.4. Conclusions 
 In its present design, BSI is capable of measuring binding of a metal ion to an 
organic ionophore molecule with signal changes that are more than an order of magnitude 
smaller than those observed for biochemical systems, less than 10 milliradians.  
Additionally, BSI was shown to detect selective ion-recognition, as 18C6 complex with 
sodium produced a signal barely above the noise of the data.  BSI KD values displayed 
excellent agreement with values determined via ITC for 18C6 and ionophore II.  Despite 
having very similar affinities for potassium, ionophore II generated a 31.6% larger signal 
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than 18C6.  Ionophore II forms a “closed clamshell” upon complexation with potassium, 
a conformational change that mimics some larger proteins’ as they bind to a ligand, while 
18C6’s conformational change upon binding with potassium is smaller.   
BSI KD values for ionophore I were not in agreement with ITC, but this is likely 
due to the fact that the ITC experiments were run at 2.0 mM ionophore while BSI 
experiments were run at only 150 nM; this was the lowest concentration of ionophore 
used in this study, as ionophore I had a significantly higher affinity for potassium 
compared to the other ionophores.  Ionophore I, also known as Valinomycin, contracts 
into a “tennis ball seam” conformation to accommodate binding to potassium, so that the 
six ester oxygen atoms are bound to the potassium ion inside the ionophore, while the 
outer surface remains hydrophobic.  Considering the probe volume of the instrument 
(7.52 nL), at the lowest concentration of potassium added to the highest-affinity system, 
30 nM with ionophore I, BSI’s limit of detection was 136 million molecules. 
This study paves the way for future small molecule or ion-recognition system 
studies, including potential environmental studies, for example targeting a specific metal 
ion in water samples.  Small-molecule systems such as the ionophores discussed in this 
chapter also serve as an important starting point to continue to refine the FreeSRF 
expression, particularly for organic, nonaqueous systems.  
 These systems have the advantage of being simpler to model and calculate 
computationally for determining model χ values compared to large proteins or other 
biomolecules.  An “extra small” training set can be developed from these studies to allow 
fitting coefficients A-E to be determined.  Their small size and the potential to run 
identical experiments in various solvents allow for a more thorough understanding of the 
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role of solvation in the BSI signal to be acquired.  Some systems, such as ionophore III, 
were shown to generate a more complicated binding curve rather than the typical one-site 
binding hyperbola.  This could help give insight into the direction of the signal. 
 The signal direction has been related to increases or decreases in RI, specifically 
for the alignment of this instrument, a negative signal change corresponds to an increase 
in RI.  Gestwicki and coworkers related this to an increase in Rh
 
upon complexation.
29
  
Using bound and unbound structures of 18C6 and ionophores I and II, it was determined 
that all three featured a decrease in Rgyr upon complexing with potassium.  Rh and Rgyr, 
while sounding similar, measure different aspects of a molecule or complex, with Rh 
taking into account the solvation sphere of the molecule in question, and Rgyr being a 
mass-weighted calculation.  Differences in these values may provide additional insight 
into the source and direction of the BSI signal.   
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 Chapter 5 
Conclusions and Future Work 
   
As a unique analytical technique, BSI offers several advantages over other 
analytical techniques in its ability to perform binding assays at physiological conditions, 
with low sample amounts, label-free and in free-solution.  These advantages provide 
straightforward experiments with a wide variety of binding partners in their native states; 
the experiments discussed in this thesis alone involved three very different types of 
interactions: 1) enzyme-inhibitor, 2) dsDNA hybridization, and 3) small molecule-ion 
recognition.  Each of these demonstrates BSI’s versatility as a RI detector, and show that 
additional information can be gleaned from the data.  Additionally, they demonstrate a 
few of the experiments that will aid in refining the FreeSRF model that describes the 
origin of the BSI signal. 
 The results discussed in Chapter 2 demonstrated that BSI data can be used in 
conjunction with other techniques to gain insight into a potential enzyme inhibitor’s 
inhibition mechanism.  BSI experiments performed with AChE and inhibitors yielded KD 
values that could be compared to IC50 values obtained in an assay that uses a high 
concentration of substrate via the Cheng-Prusoff relationship.
1
  If the KD is equal to the 
IC50, the inhibitor’s affinity to the enzyme-substrate complex is the same as its affinity to 
the enzyme alone, meaning that it has affinity solely for the peripheral site. This is 
especially useful when screening for noncompetitive inhibitors of AChE, which have 
been shown to be most effective for treating Alzheimer’s symptoms, as the peripheral site 
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aids in the aggregation of plaque precursors.  The instrument was also able to detect dual-
binding inhibitors that have affinity for both the active site and peripheral site, and bind 
in non-equivalent manners to generate two separate, rise-to-max binding curves.  This 
study highlighted BSI’s potential as a useful screening tool for potential inhibitors or 
ligands of a target enzyme or protein. 
 Previous BSI experiments examined the differences in affinities between DNA 
oligonucleotides with complementary sequences and those containing two adjacent 
mismatched base pairs.
2
  The experiments described in Chapter 3 expanded on this study 
to determine BSI’s ability to distinguish between a single mismatch or deletion, and also 
the location of the SNP in the sequence compared to the complementary DNA duplex.  
These experiments revealed that the binding strand containing a T deletion formed a 
more stable duplex than the strand containing an A/G mismatch in the same location, and 
a centrally-located SNP was more destabilizing than the same SNP in a location closer to 
the end of the sequence.  Results also correlated with melting transition studies. 
These results highlight the potential of the instrument to be used in a diagnostic 
setting, especially as fields of personalized medicine become more common and a better 
understanding of the role of genetics in human health is obtained.  Additionally, insight 
into the origin of the BSI signal resulted from the simple observation that the 
complementary duplex had a significantly higher signal compared to the SNP-containing 
duplexes.  Evaluation of the signal origin with nucleic acid experiments such as these will 
help further develop the FreeSRF model for BSI. 
 The impressive sensitivity of BSI is demonstrated in the nonaqueous, small-
molecule ion-recognition systems described in Chapter 4, including 18-Crown-6, 
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potassium ionophore I (also known as valinomycin), potassium ionophore II, and 
potassium ionophore III.  Signals more than an order of magnitude smaller than those 
obtained in the DNA hybridization experiments are obtained, and result in binding curves 
that yield KD’s that are in excellent agreement with those determined via ITC.  The 
FreeSRF expression attributes the RI change upon binding to changes in the bulk intrinsic 
properties of the newly-formed product or complex, specifically the radius of gyration 
and solvent-accessible surface area.  These small molecule systems have ∆Rgyr less than 
0.5 Å, but some of the conformational changes studied, including the “clamshell” 
ionophore II and valinomycin, mimic those seen in larger proteins but on a smaller scale.  
Ionophore III produced a unique result, a binding signal that changed direction before 
saturation; this was attributed to the presence of the dodecyl tail in the center of the 
carbon linker that alters the overall hydrodynamic radius of the complex, first increasing, 
then decreasing as the clamshell complex is formed.   
These studies allow insight into how FreeSRF is affected with small changes, and 
how differences between aqueous and nonaqueous systems can continue to be studied 
with other similar systems.  They also provide a starting point to a new training set of 
nonaqueous, small molecule binding systems in order to model and refine FreeSRF.  
These studies also highlight BSI’s ability to selectively detect a target metal ion, 
providing a potential application in metal sensing for environmental concerns.  Taken 
together, the experiments discussed in these chapters highlight BSI’s versatility and 
sensitivity with a variety of binding partners, and the additional information that BSI 
binding data can provide.   
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5.1. Determining Stoichiometry from BSI binding experiments 
Data from typical BSI experiments are used to plot a binding curve in order to 
determine binding affinity via kD values.  Plots are generated as a function of phase shift 
in radians versus concentration of analyte, and fitted to a rise-to-max one-site binding 
hyperbola: 
   
      
     
 
      (1) 
In this one-site binding hyperbola equation, y is the phase shift of the signal in 
radians, x is the concentration of analyte, Bmax  is the maximum binding capacity, and kD 
is the dissociation constant. This method has been used to determine binding affinities for 
a variety of systems, from hydrogen-bonded compounds to proteins and ligands.  By 
instead plotting phase shift versus molar ratio of analyte and fitting the curve to a similar 
equation, it is possible to obtain an approximation of the stoichiometry of the 
interaction.
3,4
   
   
      
    
 
      (2) 
In this equation, x is now the molar ratio of the analyte, and the stoichiometry of 
the solution is the point at which the sloped portion of this curve intersects the tangent of 
the saturated portion.  To determine the stoichiometry using this method, the equation of 
the tangent can be obtained by the following equation:
5
  
       
  
  
              (3) 
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The slope of the tangent at point (X,Y) is dy/dx, which is shown below: 
  
  
 
      
      
 
      (4) 
The slope of the initial, steep portion of the binding curve is determined by linear 
regression, and extended to determine the intersection with the tangent.  The value of the 
x-axis where this intersection occurs is the approximated stoichiometry of the binding 
interaction.  This method is most straightforward with 1:1 stoichiometry, but also works 
for higher stoichiometry as long as the signal changes are equivalent.  Below are several 
examples of previous BSI experiments and the stoichiometry determined using the 
described method. 
5.1.2. Stoichiometries of BSI binding systems 
 
Figure 5.1.  Phase shift vs. Molar Ratio of Complement DNA strand plot of dsDNA 
binding data with initial linear portion and tangent at x = 1.5, which results in an 
intersection at x = 0.85. 
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Figure 5.2.  Phase shift vs. Molar Ratio of potassium ion to ionophore I binding data 
with initial linear portion and tangent at x = 5, which results in an intersection at x = 0.82. 
 
  
 
Figure 5.3.  Phase shift vs. Molar Ratio of TMAB to DNPU BSI binding data with initial 
linear portion and tangent at x = 5, which results in an intersection at x = 1.3. 
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Figure 5.4.  Phase shift vs. Molar Ratio of Ca
2+
 to CaM BSI binding data with initial 
linear portion and tangent at x = 10, which results in an intersection at x = 5.1. 
 
 Figures 5.1-5.4 show the binding curves of four BSI systems: 1) Complementary 
DNA duplex (Chapter 3), 2) potassium ion with ionophore I (Vm, Chapter 4), 3) TMAB-
DNPU hydrogen bonds (Pesciotta)
6
, and 4) calcium ion with calmodulin (Bornhop)
7
.  
The first three systems all showed the expected 1:1 stoichiometry, and the Ca
2+
-CaM 
system data resulted in a stoichiometry of about 5:1.  The expected stoichiometry is 4:1, 
but nonspecific binding of calcium would increase the apparent stoichiometry from the 
data.  This method of approximating the stoichiometry of the binding partners does not 
work for systems with nonequivalent signals from additional binding, such as the dual-
binding inhibitors of AChE discussed in Chapter 2, but for many binding systems it 
provides additional information with no additional experiments.    
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5.2. Observing decomplexation with BSI 
 Valinomycin’s effectiveness as an ionophore across bacterial membranes lies in 
its ability to sequester a potassium ion in the center of its ring with the polar ester 
carbonyls while the outside of its ring remains hydrophobic.  The complex is unstable in 
aqueous media, and Forester and coworkers used computational studies to observe the 
decomplexation of the potassium complex as it enters an aqueous environment, as shown 
in Figure 5.5.
8
 
 
Figure 5.5. Simulation of the decomplexation of the VmK
+
 complex as increasing 
amounts of water (shown in blue) are added.
8
 
 
 This type of interaction should also generate a significant ∆RI, as addition of 
water molecules to hydrate the potassium ion induces a conformational changes to the 
valinomycin molecule.  BSI experiments were designed with a constant concentration of 
VmK
+
 complex (150 nM) and increasing amounts of water, to observe if any signal 
changes occur with additional equivalents of water.  The BSI data are shown in Figure 
5.6. 
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Figure 5.6. Phase Shift vs. Molar Ratio of water to VmK
+
 BSI data. 
 
The most significant change is seen when going from four to five equivalents of 
water, but changes in signal direction are observed at as low as one or two equivalents.  
Experiments could be set up similarly and monitored using techniques such as NMR to 
correlate these changes with structural changes to continue to improve our understanding 
of the origin of the BSI signal and the FreeSRF expression.  In these ways, experiments 
beyond the typical binding experiments could be designed to obtain more information on 
a desired system. 
5.3. Future Work with BSI 
 Future research with BSI could continue in several different directions, owing to 
its excellent sensitivity and an ever-improving understanding of the instrument.  
Alterations to the instrument itself could help mitigate noise due to environmental 
factors, such as air currents, temperature, or pressure changes, including allowing for 
reference and sample to be measured simultaneously.  BSI remains a desirable platform 
for many biochemical systems due to its small sample sizes and ability to measure native, 
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unperturbed binding affinities.  It can be used as an effective screening tool for potential 
drug compounds. 
 Small molecule, metal-ion sensing is a largely unexplored field with BSI that 
shows great promise, as demonstrated with the potassium ionophores in Chapter 4.  
Similar metal-ion recognition studies could be designed for metal catalyst studies, 
environmental studies, or medicinal purposes.  Mercury has been shown to insert 
selectively into T-T DNA base pairs.
9
  Experiments with BSI could be designed for Hg-
ion detection based on poly-thymine sequences that self-hybridize upon addition of Hg. 
 Other ionophores could be studied for their potential as medicinal compounds, 
including potential antibiotic agents.  Recently, a report by Arnoux and coworkers 
introduced a new natural-product based metallophore named staphylopine, shown in 
Figure 5.7.
10
 
 
Figure 5.7. Structure of staphylopine 
 Staphylopine was shown to be similar in structure to nicotianamine, a metal 
chelator found in plants, which enables them to obtain necessary metals.  This compound 
is found in some bacteria, and was shown to have affinity for a variety of divalent metal 
cations.  Bacteria require metal cations from their host, so this presents a potential target 
for fighting bacterial infection, either by 1) targeting parts of the biosynthetic cycle that 
produces staphylopine, or 2) by using analogs to introduce toxic metals into the bacteria 
cells.  Analytical techniques such as BSI could be useful in screening potential 
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compounds for the former case, and ion-recognition experiments could be designed to 
evaluate ions’ affinities for the latter case. 
 Small molecule studies with BSI also act as ideal model systems to continue to 
evaluate the FreeSRF expression.  Solvent effects can be analyzed by performing 
identical experiments in different solvents, or solvent mixtures.  For example, hydrogen 
bonding studies performed in pure MeCN versus a 9:1 MeCN:water mixture could result 
in different signal magnitudes that yield insight into solvation effects on RI changes.  
Similarly, protic solvents like methanol would be expected to have an impact on the 
complexation of 18C6 with potassium, both in terms of binding affinity (ITC experiments 
showed a slightly larger KD of ca. 20 μM compared to ca. 3 μM in MeCN), and signal 
magnitude, due to the possibility of hydrogen bonds to solvent.
11
  Solvent choice is 
limited by its RI; there must be a large enough difference in the RI of the chip and the 
solvent in order for a high-contrast fringe pattern to be generated, and some solvents, 
including methanol, adsorb to borosilicate glass.  These factors can be avoided with chips 
made out of different materials, or by surface modification.  Another advantage of using 
small molecule systems to evaluate the FreeSRF expression is the relative ease of 
computer modeling these systems compared to large, biochemical systems including 
proteins or nucleic acids. 
 
5.4. Concluding Remarks 
 The versatility and sensitivity of BSI make it a powerful analytical technique for a 
wide variety of chemical interactions.  The studies discussed in this thesis covered three 
very different types of interactions, including enzyme-inhibitor, DNA hybridization, and 
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small-molecule ion-recognition.  It has the potential to serve as a screening tool for 
potential drugs, a diagnostic tool for detecting biomarkers such as SNPs, and a selective 
ion sensor.  Using these studies and future experiments to expand on, and continually 
refine, the FreeSRF expression will help researchers develop a more thorough 
understanding of BSI data, and RI detection as a whole.  With potential detection limits 
of less than 100,000 molecules for biochemical systems in free-solution and label free, 
BSI helps decrease sample amounts and preparation time.  These factors, plus its 
straightforward experimental procedure, make it an ideal candidate for application to 
many laboratory environments, and we hope that this research assists in making BSI or 
other universal RI detectors more widely available for chemists. 
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